HALFORDS SUPPORTS NEW INFRASTRUCTURE ACT

Halfords, the UK’s leading cycle retailer, welcomes the Government’s new infrastructure act. The act means the Department for Transport will have to improve the existing network of existing cycling routes and infrastructure. It also means that civil engineers will have to give strong consideration to cycling when planning for the future. Emma Fox, Commercial Director at Halfords says: “This act will help create the cycling revolution that the Government promised several years ago. It’s important that cyclists everywhere are catered for and having the right infrastructure in place will help everyday cyclists go to school, to work or cycle just for fun and enjoyment.” Halfords recently commissioned a YouGov state-of-the-nation report on cycling safety which reveals how important cycling infrastructure is to the nation and what they think can be done to improve it. 40 per cent of those questioned believed that there should be dedicated cycling lanes on every road, while 16 per cent supported New York style high rise cycle ‘Super Highways’. A further 20 per cent called for more places to park and lock their bikes. Emma Fox continues: “Support on a national level is vitally important. According to our recent research the announcement will be welcome by most across the UK – over 55 per cent believe the Government should give more attention and investment to cycling safety.” -ENDS- All figures, unless otherwise stated, are from YouGov Plc.  Total sample size was 4468 adults. Fieldwork was undertaken in November 2015.  The survey was carried out online. The figures have been weighted and are representative of all GB adults (aged 18+).

Cortendo to Join Patients, Families and Pennsylvania Legislators to Raise Awareness for Rare Diseases

February 23, 2015 -- Harrisburg, PA, USA – Cortendo AB (http://www.cortendo.com) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on developing new solutions for rare diseases that is based in Radnor, Penn., is pleased to participate in the Rare Disease Day® event at the Pennsylvania State Capitol Building on Tuesday, February 24. Matthew Pauls, President and CEO of Cortendo, joins patients and their families, physicians and legislators to help raise awareness for the 30 million Americans currently living with a rare disease. The event is Tuesday, February 24, 11:30 a.m. to 1:30 p.m., at the State Capitol Building, East Wing Rotunda. “I am honored to join patients and their families, physicians, and leaders of the Commonwealth of Pennsylvania at this important event, and I look forward to hearing about their perspectives and insights in dealing with rare diseases,” said Pauls, who will be speaking about the role of industry in rare disease drug development. “Their stories of challenge, triumph and hope are both motivating and inspiring to Cortendo employees and undoubtedly to others working hard to find new and better solutions.” Cortendo’s lead investigational drug is COR-003 (levoketoconazole), which is being studied in the global Phase 3 SONICS trial for the treatment of Cushing’s syndrome. COR-003 (levoketoconazole) has received orphan designation from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).  According to the National Institutes of Health (NIH), a disease is rare if it affects fewer than 200,000 Americans. One in 10 Americans live with a rare disease—affecting 30 million people—and two thirds of these patients are children. There are more than 7,000 rare diseases but only approximately 450 FDA-approved medical treatments. Many rare diseases are not being studied by medical researchers. Rare Disease Day is an annual awareness day celebrated around the world and dedicated to elevating public understanding of rare diseases and calling attention to the special challenges faced by these patients. Rare Disease Day takes place every year on the last day of February (February 28, or February 29 in a leap year)—the rarest date on the calendar—to underscore the nature of rare diseases and what patients face. Rare Disease Day was established in Europe in 2008 by EURORDIS, the organization representing patients with rare diseases in Europe, and is now observed in more than 80 nations. Rare Disease Day is sponsored by the National Organization for Rare Disorders (NORD®), a leading independent, nonprofit organization committed to the identification, treatment, and cure of rare diseases. The Pennsylvania event on Tuesday is co-sponsored by NORD and the Connexion Healthcare Rare Disease Center of Excellence. Connexion Healthcare is an award-winning, full-spectrum healthcare communications company founded in 1999, and its Rare Disease Center of Excellence specializes in effectively communicating the science behind rare diseases and orphan drugs, and members have a personal connection with, and passion for, assisting patients and caregivers affected by rare diseases. For more information about Rare Disease Day in Harrisburg and registration, go to http://bit.ly/PArareDay. For information about global activities, visit www.rarediseaseday.org. To search for information about rare diseases, visit the NORD Web site at www.rarediseases.org. About Cortendo ABCortendo AB is a global biopharmaceutical company incorporated in Sweden and based in the United States. The Company’s strategic focus is to be the global leader in commercializing innovative medicines for orphan endocrine disorders. Cortendo is leading the way in the field of cortisol inhibition through the investigational drug, COR-003 (levoketoconazole), currently being studied in the global Phase 3 SONICS trial for the treatment of Cushing’s syndrome. COR-003 (levoketoconazole) has received orphan designation from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The Company’s intent is to independently commercialize its Orphan/Endocrine assets in key global markets and partner non-strategic product opportunities, such as diabetes, at relevant development stages. Risk and UncertaintyThe development of pharmaceuticals carries significant risk. Failure may occur at any stage during development and commercialization due to safety or clinical efficacy issues. Delays may occur due to requirements from regulatory authorities, difficulties in recruiting patients into clinical trials due to physician or patient preferences or competing products, not anticipated by the Company. There is no assurance that Cortendo will receive marketing and regulatory approvals necessary to commercialize or produce COR-003 (levoketoconazole) or other products. Regulatory approvals may be denied, delayed, limited or revoked. The commercial success of COR-003 (levoketoconazole), if approved in a territory, cannot be predicted with certainty. In addition, Cortendo may face the risk of interrupted supply of COR-003 for clinical or commercial use from the subcontractors Cortendo has contracted. Cortendo Forward-Looking StatementsThis press release contains forward-looking statements concerning Cortendo that involve a number of risks and uncertainties. All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, plans, projects to enhance efficiency, outcomes of products development, future capital expenditures, liquidity requirements and objectives of management for future operations, may be deemed to be forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements or industry results to be materially different from those contemplated, projected, forecasted, estimated or budgeted, whether expressed or implied, by these forward-looking statements. Given these risks and uncertainties, investors should not place any undue reliance on forward-looking statements as a prediction of actual results. None of these forward-looking statements constitutes a guarantee of the future occurrence of such facts and data or of actual results.  These statements are based on data, assumptions and estimates that the Company believes are reasonable. The forward-looking statements contained in this document are made only as of the date hereof. The Company expressly disclaims any obligation or undertaking to release publicly any updates of any forward-looking statements contained in this press release to reflect any change in its actual results, assumptions, expectations or any change in events, factors, conditions or circumstances on which any forward-looking statement contained in this press release is based. ### Corporate:Alexander LindströmChief Financial Officer, Cortendo AB+1 610-254-9200alindstrom@cortendo.comInvestors and Media:LaVoieHealthScienceDonna LaVoie and David Connolly+1 617-374-8800dlavoie@lavoiehealthscience.comdconnolly@lavoiehealthscience.com Sweden:Box 47SE-433 21 PartilleTel. / Fax. +46 (0)31-263010USA:555 East Lancaster Ave.Suite 510Radnor, PA 19087Tel. +1 610-254-9200Fax. +1 610-254-8005

Music Video Highlights Racism in Football Following Recent Incident with Chelsea Fans in Paris

Last week shocking footage emerged that showed a group of British football fans shouting racist chants and stopping a black man from boarding the metro in Paris. This incident, which has been widely condemned by the Chelsea football club and the supporter’s association, coincides with the release of a new music video which has been produced to challenge racism and change people’s perceptions. Created by FMS Media, in association with Artists for Peace, The Final Game (https://www.youtube.com/watch?v=v5TA4z6oxvw&feature=youtu.be) is the first in a series of Stop Racism campaign music videos and features a multitude of celebrities giving their messages of tolerance and peace. Aram Sargsyan, Co-Founder of France-based FMS Media said, “The actions of a few racist football fans have shocked France and the UK, but this metro incident emphasises the seriousness of racism. It is ridiculous that in the 21stcentury anybody can be publicly humiliated and assaulted simply for the colour of their skin. Racism is constantly linked to football in Europe and around the world, which is why we decided to feature it in The Final Game.” Just last year a Barcelona football player was racially abused during a match, when a member of the crowd threw a banana at him. The defender then picked up the fruit and ate it, kick-starting a worldwide debate about racism in football. “It was actually that banana incident with Dani Alves which inspired the song and the story in the video,“ explains Aram Sargsyan. “Whether racism is shown to football players, fans, or random members of the public such as the man trying to board the Paris metro, it is wrong and together with Artists for Peace we aim to make the world a more tolerant place.” The Final Game features vocals from a range of artists hailing from all over the world, such as Devon T, Rina Cervantes, OP1 and Kantana. The humorous video also features actor Ken Davitian as a main character, who is famous for big screen roles in Borat, The Artist and Meet The Spartans. Towards the end of the powerful music video, various singers and celebrities give their messages of anti-racism, respect and peace. Stevie Wonder and Chaka Khan make an appearance, as well as Martinican singer Jocelyn Beroard who speaks against racism in French. In light of the recent football related racist events, FMS Media are calling upon the public to make the video go viral and reach millions of views. If The Final Game proves popular then FMS Media will be able to raise funds to continue the anti-racism campaign and produce more videos. Aram Sargsyan added, “We invite you to stand up to racism and change the world – share this video.”To watch The Final Game on YouTube, visit: https://www.youtube.com/watch?v=v5TA4z6oxvw&feature=youtu.be   Facebook: https://www.facebook.com/FMSMedia Twitter: https://twitter.com/FMS_Media To find out more about FMS Media, click here: http://www.fmsmedia.com To find out more about Artists for Peace, click here: http://artistsforpeace.fr/ Pictures Credit - Paul Nolan for The Guardian http://www.theguardian.com/football/2015/feb/18/chelsea-football-club-calls-fans-help-find-racists-paris-metro-footage

Key contract win for Driveline worth EUR 83 million (NOK 714 mill)

Kongsberg Automotive (KA) has received nomination from a major Global OEM for supply of the complete manual gear shifter system to a global platform. The shifter system will be used in B Segment cars which will be sold in Europe, South America and Asia under two different brands. The contract has a total value of 83 MEUR over 7 years. Production supply will be out of 6 plants Cluses (France), Vrable (Slovakia), Wuxi (China), Jundiai (Brazil), Gurgaon (India) and Nuevo Laredo (Mexico). Production will start in H1 2016 with a peak volume in 2020. KA continues to leverage the benefit of being a global player with 32 manufacturing locations in 20 countries. “It’s very satisfying that we are able to bring products to the market which contribute to a sustainable future”, said Joachim Magnusson, Executive Vice President at Kongsberg Automotive’s Driveline business area. Media: Hans Peter Havdal, President & CEO Phone: +46 92 06 56 90 E- mail: Hans.Havdal@ka-group.com Investors / analysts: Philippe Toth, SVP Business Development & IR Phone: +47 98 47 34 50 E- mail: Philippe.Toth@ka-group.com About Kongsberg Automotive: Kongsberg Automotive provides world class products to the global vehicle industry. Our products enhance the driving experience, making it safer, more comfortable and sustainable. With revenues of close to EUR 1.0 billion and approximately 10.000 employees in 20 countries, Kongsberg Automotive is truly a global supplier. The company is headquartered in Kongsberg, Norway and has 32 production facilities worldwide. The product portfolio includes seat comfort systems, driver and motion control systems, fluid assemblies, and industrial driver interface products developed for global vehicle manufacturers. Find more information at www.kongsbergautomotive.com

London Artisan Patisserie Introduces the UK to S’mores

Renowned Kensington Patisserie is proud to launch its brand new decadent treat – the S’more. Traditionally an American campfire favourite, the Anges de Sucre range of S’mores (http://www.angesdesucre.com/collections/smores) has a signature British flair and is made with premium ingredients including the finest Belgian chocolate and organic vanilla pods. Each indulgent, hand-crafted S’more is lovingly made with own-recipe rye biscuits – taking inspiration from the iconic American Graham cracker – topped with homemade gourmet marshmallows and a thick, generous layer of smooth Belgian chocolate. The impeccable result of the different textures married with the tempting flavours is a delectable sweet snack to be loved by all ages. Reshmi Bennett, Founder of Anges de Sucre says, “Anyone with a sweet tooth will adore a S’more. I’ve been a fan of the North American traditional treat since I was a child living in Canada, but the Anges de Sucre S’mores are a superior, grown-up version of the campsite treat. We make each element from scratch, where the rye biscuits are also infused with cinnamon and acacia honey and our marshmallows are utterly mouth-watering.” As each separate ingredient is handmade by the boutique patisserie, Anges de Sucre has invented a number of variations on the classic S’more. There are three different taste bud tantilising flavours available: Golden Graham – a fluffy vanilla bean pod mallow, sandwiched in between two cinnamon-sugar rye biscuits and finished off with Belgian chocolate and smooth sea-salted caramel. Triple Chocolate – cocoa rye biscuits with a delicious chocolate marshmallow, dark chocolate ganache and a sumptuous layer of sea-salted caramel. PB – A nod to the other side of the pond, the PB is the ultimate American dream with organic peanut butter and Belgian chocolate dripping from a vanilla pod marshmallow, held together by two cinnamon-sugar rye biscuits. Each beautiful indulgence is available loose in-store at the Kensington sweet shop, or can be ordered online in assortments of three for UK-wide delivery, or in large quantities for events, parties and weddings. The brand new range of S’mores are the latest creation from the artisan patisserie, which has become renowned for its high-end tasty treats including its very own invention, the Muffle. Reshmi added, “Our S’mores offer that perfect combination of savoury and sweet which makes the ultimate delicacy. They would make the perfect Easter gift for someone who finds the traditional chocolate egg too rich.” To find out more about Anges de Sucre and its delectable gourmet sweets, visit the website: http://www.angesdesucre.com/ Instagram: https://instagram.com/angesdesucre/  

The Nomination Committee’s proposal for board of TradeDoubler AB (publ)

The Committee proposes that Peter Åström is elected as a new member of Tradedoubler’s board and that, Martin Ahrend, Thomas Bill, Martin Henricson, Peter Larsson and Mernosh Saatchi are re-elected. Peter Larsson is proposed to be re-elected as chairman of the board, which according to the proposal will consist of six ordinary members and no deputies. Peter Åström is the MD and founder of EBC Executive Board Consulting AB. Peter holds an MBA and has previously been the MD for Entraction Holding AB, a company in the digital gaming industry, and he has also been the MD for several companies including within the Schibsted and Brio group of companies respectively. Peter is the chairman of the board of Betting Promotion Sweden AB and a member of the board of Nordic Leisure AB, both companies listed on First North, as well as a member of the board of Sportway AB. The proposal fulfils the requirements regarding diversity and breadth of qualifications, experience and background of the board members.The Nomination Committee has consisted of Thomas Bill, appointed by Monterro 1A AB (Chairman), Henrik Kvick, appointed by Henrik Kvick AB, Jannis Kitsakis, appointed by Fjärde AP-fonden Strandberg, and Peter Larsson, Chairman of the board. The full proposal from the Nomination Committee will be presented at the company’s website in connection with the publication of the notice for the annual general meeting.   The Annual General meeting will be held Tuesday, May 5, 2015 in Stockholm. Stockholm 23 February, 2015TradeDoubler AB (publ.) The information in this announcement is required to be disclosed by TradeDoubler AB under the Swedish Securities Markets Act (Sw. lagen om värdepappersmarknaden). This information was released for publication at 15.00 CET on February 23, 2015.

6.5 Million Men in the UK are affected by Male Pattern Baldness

Within the UK alone, a staggering 6.5 million men are affected by male pattern baldness, a hereditary condition which affects nearly half of all men by the time they turn 50. With hair loss connected to loss of self-esteem and confidence, the experts at Hair Development offer a plethora of hair loss solutions embraced by men worldwide. Male pattern baldness typically occurs during a man’s late twenties or early thirties with many men experiencing some form of hair loss by their late thirties. As the most popular form of hair loss in men, male pattern baldness typically takes the form of a receding hairline emphasised by thinning of the hair on the crown and temples - lending the noticeable horseshoe shape that characterises the condition. Known to be passed down from the mother’s side of the family and also to skip a generation, the condition is linked to an excess of male hormones. Mark Burns, Managing Director of Hair Development said, “Male pattern baldness is incredibly common and yet the ramifications of the condition are tremendous. Many men report a lack of confidence, loss of self-esteem, anxiety and depression. A full head of hair signals youth and fertility so once a man experiences hair loss, the impact can be extreme. Fortunately men no longer need to suffer in silence. We’ve developed many advancements in hair loss technology to subtly and completely conceal the condition.” With over 50 years of industry expertise, Hair Development offers a range of services designed to resolve hair loss issues. With an option to suit everyone, clients can book a direct consultation to discuss their needs, most appropriate fit or even to develop a bespoke solution. Amongst the extent of options is laser hair re-growth therapy, which is approved by the FDA and scientifically proven to trigger re-growth. Non-surgical hair replacement provides undetectable results and offers a non-evasive alternative. Miracle Graft hair replacements offer a non-surgical alternative which is virtually undetectable. Other options include the Crystal Lace Micro graft hair replacement which includes a staggered hairline and optimum styling opportunities, the continuous hair graft which implants one strand at a time and Celebrity Lace, a tried and tested A-list favourite which mimics the production of naturally growing hair from the scalp. Customers can also opt for Skinvisible, a stretchable solution ideal for extreme hair loss including alopecia. Mark added, “A healthy head of hair isn’t just about aesthetics; although of course it looks great, it’s also about helping a person to feel confident and comfortable in their own skin. So many men struggle with hair loss but there is a solution.” To find out more about Hair Development’s plethora of hair loss treatments and solutions for men visit http://www.hair-development.com

French competition authority approves divestment of Hygena

As previously announced, Nobia signed an agreement for the sale of the Hygena kitchen chain to Fournier Group for a purchase consideration of EUR 20 million on a cash and debt-free basis.The sale has now been approved by the French competition authority.The transaction will take place on 2 March 2015 and its effects will be recognised together with Hygena’s operating result for the first two months of the year under the heading “Discontinued operations” in the income statement.For 2014, the divestment of Hygena had a negative earning effect of SEK 487 million, attributable to the impairment of goodwill and deferred tax assets, and expenses related to the sale. For further details, refer to the interim report for the fourth quarter of 2014.Nobia’s Continental Europe region will be renamed Central Europe region after the divestment of Hygena.For further information:Mikael Norman, CFO+46 (0)8 440 16 09 or +46 (0)705 94 57 29mikael.norman@nobia.comNobia develops and sells kitchen solutions through some twenty strong brands in Europe, including Magnet in the UK, Hygena in France, HTH, Norema, Sigdal, Invita and Marbodal in Scandinavia and Petra, Parma and A la Carte in Finland, ewe, Intuo and FM in Austria, as well as Poggenpohl globally. Nobia creates profitability by combining economies of scale with attractive kitchen offerings. The Group has approximately 6,900 employees and sales of about SEK 12 billion in 2014. The share is listed on Nasdaq Stockholm under the ticker NOBI. Website: www.nobia.com

Notice of Annual General Meeting

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENTOslo, 23 February 2015: The Board of Directors of Nordic Nanovector ASA (“Nordic Nanovector” or the “Company”) calls for the Annual General Meeting of Nordic Nanovector to be held on Monday 9 March 2015 at 15:00 hours (CET) at the Company’s offices in Kjelsåsveien 168 B in Oslo, Norway. The attached notice of the Annual General Meeting includes items regarding approval of the annual accounts for the financial year 2014 and other customary matters for the Annual General Meeting. In addition, the Board of Directors proposes that the General Meeting resolves to increase the share capital of the Company and to grant the Board of Directors with an authorisation to increase the share capital in connection with the contemplated initial public offering (the “IPO”), as well as to grant the Board of Directors with an authorisation to increase the share capital in connection with and the employee share incentive arrangements.The Annual General Meeting shall also elect members of the Board of Directors and members of the Nomination Committee. The Nomination Committee will propose such members and remuneration for such members, and the proposal will be made available on the Company’s website www.nordicnanovector.com. The annual accounts and the annual report for the financial year 2014 are in accordance with the first paragraph of Section 7 of the Articles of Association available on the Company’s website www.nordicnanovector.com. The background for the proposals is further set forth in the attached notice of the Annual General Meeting. The notice is also available on the Company’s website www.nordicnanovector.com. INFORMATIONLuigi Costa, CEOCell:    (41) 79 124 8601  Fax:    (47) 22 58 00 07E-mail: lcosta@nordicnanovector.comTone Kvåle, CFOCell:    (47) 91 51 95 76Fax:    (47) 22 58 00 07E-mail: tkvale@nordicnanovector.comFurther information about the Company can be found at www.nordicnanovector.com.About Nordic NanovectorNordic Nanovector was established in 2009 and has its main office and laboratories in Oslo, Norway. The Company aspires to become a leading provider of Antibody-Radionuclide-Conjugate (“ARC”) clinical solutions, to address major unmet medical needs and to advance cancer care through its innovative therapy programs and patented technologies. The Company intends to directly commercialize its product candidates, by creating a differentiated and specific positioning, investing in cross-specialty collaboration and medical education. The Company is also committed to continue developing the ARC pipeline leveraging on its proprietary nanovector targeting technology.The Company’s lead product candidate, Betalutin™, is an Antibody-Radionuclide-Conjugate that aims to prolong the survival and improve the quality of life of patients who suffer from non-Hodgkin Lymphoma (“NHL”), a life-threatening blood cancer with a high unmet medical need. The product candidate is currently undergoing a Phase I/II clinical trial for treatment of relapsed NHL. Further information about the Company can be found at www.nordicnanovector.com.IMPORTANT INFORMATION United StatesThese materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the “Shares”) of Nordic Nanovector ASA (the “Company”) in the United States, Norway or any other jurisdiction. The Shares of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The Shares of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to “qualified institutional buyers” as defined in Rule 144A under the U.S. Securities Act. European Economic AreaAny offering of securities will be made by means of a prospectus to be published that may be obtained from the issuer or selling security holder, once published, and that will contain detailed information about the Company and its management, as well as financial statements.These materials are an advertisement and not a prospectus for the purposes of Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not subscribe for any securities referred to in these materials except on the basis of information contained in the prospectus.In any EEA Member State other than Norway (from the time the prospectus has been approved by the Financial Supervisory Authority of Norway, in its capacity as the competent authority in Norway, and published in accordance with the Prospectus Directive as implemented in Norway) that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at “qualified investors” in that Member State within the meaning of Article 2(1)(e) of the Prospectus Directive (“Qualified Investors”), i.e., only to investors to whom an offer of securities may be made without the requirement for the Company to publish a prospectus pursuant to Article 3 of the Prospectus Directive in such EEA Member State. United KingdomIn the United Kingdom, these materials are only being distributed to and are only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as “Relevant Persons”). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. 

Year-end report 2014

October-December 2014 · Consolidated revenue for the period is 57 718 (28 718) kSEK, an increase of 101% compared to the same period 2013. · Operating result for the period is 2 352 (-20 518) kSEK. Excluding write-downs and re-listing expenses the operating result was 2 928 kSEK. · Net result for the period is 3 255 (-19 299) kSEK. · Earnings per share for the period before and after dilution is 0.37 (-2.19) SEK. · Cash flow before financing activities during the period is -260 (-6 650) kSEK. January-December 2014 · Consolidated revenue for the year is 182 116 (100 007) kSEK, an increase of 82% compared to 2013. · Operating result for the year is 9 015 (-11 826) kSEK. Excluding write-downs and re-listing expenses the operating result is 13 812 kSEK. · Net result for the year is 6 814 (-11 664) kSEK. · Earnings per share for the year before and after dilution is 0.77 (-1.34) SEK. · Cash flow before financing activities during the year is 5 090 (-20 343) kSEK. This includes fees of 2 354 kSEK to advisors in connection with the listing on Nasdaq Stockholm. · The result for the year is affected by write-downs of capitalized development costs and advances to external developers in the amount of 2 443 kSEK. · On June 10, the shares of G5 Entertainment AB (short name: G5EN) started trading on the main market of Nasdaq Stockholm. · The Board of Directors will propose to the Annual General Meeting that no dividend is paid for 2014. Important events during the fourth quarter · G5 has during the quarter shown substantial and profitable growth, and generated record monthly and quarterly revenue. · Revenue from free-to-play games grew 164% compared to 13Q4, and accounted for 84% of total revenue in 14Q4 (64% in 13Q4). · The accumulated number of downloads of the group’s games (not counting updates) surpassed 190 million. · The group continued working on improving free-to-play games in its portfolio and working on new free-to-play games. · On December 19, 2104, the company held an extra-ordinary general meeting that decided to issue a maximum of 176 000 warrants to managers and senior executives of the G5 group, in accordance with the previously decided warrant program. Important events after the end of the period · Two recently released games, both G5’s intellectual property, Survivors: The Quest and Mahjong Journey, have been received well by the market. · Martin Bauer has resigned from the Board of Directors. · Beginning with the reporting period January-March 2015, G5 Entertainment AB will start reporting revenues and costs in a functional income statement format. Operational costs will be classified as Cost of revenue, Research & development, Sales & marketing, and General & administrative costs. · Simultaneously, G5 Entertainment AB will begin reporting revenues including commission to distributors. This will increase reported revenues by approximately 40% as compared to the present revenue recognition method. · As the company currently undergoes a phase of fast top-line growth, exceeding the pace of the market expansion, the Board believes the management should focus on maintaining fast organic growth. The Board has therefore decided not to provide any financial targets with regard to the company’s future profitability at this stage. · The Group’s CFO, Odd Bolin, has decided to resign from G5, in order take up a new position. The recruitment of a replacement has started, and in the mean time Odd Bolin will continue to perform his duties. · After the extra-ordinary general meeting on December 19, 2014, the Board of G5 decided to allocate a total of 157 500 warrants to existing employees, keeping 18 500 warrants for potential new recruitments, etc. These 157 500 warrants have been fully subscribed. · The group’s office in Kharkov continues business as usual. It is the group's policy to keep critical code and materials backed up outside Ukraine, keep intellectual property rights in EU entities, and transfer funds to subsidiaries on as-needed basis.

Clavister Demonstrates Next Generation NFV-based Network Security Solution for Mobile Operators

The suite, including Small Cell, LTE Backhaul and GRX Security Gateway, is a complete NFV-based software package providing mobile network operators with a range of solutions to provide robust security to 4G and LTE mobile cores, for network operators.   The Clavister LTE Backhaul Security solution enables the flexible deployment of IPsec encryption and firewalling at scale to secure mobile data traffic from cell sites to the network core.  The solution also protects small cell stations against being used for unauthorised network access and intrusion addressing the growing need to secure mobile data backhaul between the radio and LTE core networks.  Clavister’s LTE Small Cell Security solution addresses the need to secure the fast-growing number of small base stations being deployed to address subscribers’ bandwidth needs in public areas. It features next-generation firewalling for packet core security; encryption from the eNode B to small cells, for secure data backhaul; and enables intelligent mobile data offloading to WiFi networks. The GRX Security Gateway Solution, protects operators’ mobile networks from threats and attacks targeting the GPRS Roaming Exchange (GRX) network, protecting MNOs against costly security incidents such as DoS attacks, privacy intrusions and overbilling attacks; issues that can result in substantial financial losses and damage to both brand and business. Jim Carlsson, CEO of Clavister said:  “With more operators offering 4G and LTE services it is critical that they embed security into the network to protect mobile networks and data against attack and interception.  As operators expand services available on these networks and they become increasingly central to enhance connectivity and the delivery of smart cities, robust security will be critical in preventing a wide variety of attacks.”  Clavister is a member of the Intel® Network Builders program (networkbuilders.intel.com), a cross-industry initiative that enables telcos to build and manage business-critical infrastructures, with lower capital and operating costs.  In 2015 Clavister has also started work on a number of projects to deliver secure Wi-Fi networks including the Brazil “Smart Cities” initiative, with a focus on securing wireless networks at 1600 locations in the country and with the Swedish Hockey League to provide a secure platform to offer fans value-added in stadium services. For more information on Clavister’s solutions, visit: http://www.clavister.com/solutions/

Tools from IAR Systems selected by adidas for smart personal physiological system

Embedded World, Nuremberg, Germany—February 24, 2015—IAR Systems® today announces that adidas AG Germany has selected IAR Systems’ world-leading tools for development of their product adidas miCoach Elite Team System: an advanced system for monitoring personal physiological data in real time. For several years, adidas has been using the development toolchain IAR Embedded Workbench® for ARM® in different development projects because of its ease of use and high performance. Products for the Internet of Things and wearables focusing on health are continuously growing in use and popularity. A large trend among these smart products is applications for monitoring personal physiology. The adidas miCoach Elite Team System is the first system of its kind that uses personal physiological data in real time, sending it straight to a coach's tablet on the side-line. The system not only provides real-time insights during training, but tracks total training impact, collects and manages data and is highly portable. The state of the art system measures everything from power, speed and distance to heart rate, acceleration and field position, allowing key insights into player performance and work rate, helping teams achieve and maintain peak physical performance. During the last years, the system has been rolled to several adidas football clubs and federations around the world. “Many of the most renowned companies from all parts of the world use IAR Systems’ software to develop new competitive products, and I am very proud that our tools have helped adidas to develop the smart technology of miCoach Elite Team System,” says Stefan Skarin, CEO, IAR Systems. “This is not only a proof of our widely spread customer base of 46,000 companies, it also once again shows that our tools help developers worldwide to build a smarter world.” IAR Embedded Workbench is a complete set of development tools for developing embedded applications. In addition to its sophisticated IAR C/C++ Compiler™, the tools include extensive debugging and analysis possibilities. Thanks to strong partnerships with the leading semiconductor vendors, IAR Systems is able to deliver the broadest device support in the industry covering more than 9,000 devices. This unique independence allows customers to pick and choose among the different microcontrollers, finding the perfect choice for their needs while feeling confident they will be able to maximize the features of the selected microcontroller. More information about the tools is available at www.iar.com/ew. ### Ends Editor's Note: IAR Systems, IAR Embedded Workbench, C-SPY, C-RUN, C-STAT, visualSTATE, Focus on Your Code, IAR KickStart Kit, IAR Experiment!, I-jet, I-jet Trace, I-scope, IAR Academy, IAR, and the logotype of IAR Systems are trademarks or registered trademarks owned by IAR Systems AB. All other products names are trademarks of their respective owners.

Channel 4 Selects Aspera to Transfer All its Content to the Cloud for 4oD

ARMONK, NY – 24 February 2015: Aspera (http://asperasoft.com/), an IBM company, today announced that Channel 4 (http://www.channel4.com/), the British publicly owned and commercially funded television broadcaster, has selected Aspera to enable the rapid and secure transfer of thousands of hours of video content to the cloud for its popular video-on-demand service, 4oD (4 on Demand). Channel 4 has deployed Aspera On Demand (http://asperasoft.com/software/asperaondemand/), IBM’s cross cloud high-performance transfer platform, to significantly reduce the time it takes to transfer over 100 hours of new video content each week - amounting to 100 terabytes of data a year.  Available through 22 platforms, including set-top-box services Virgin Media and Sky catch up, mobile devices, PCs, connected TVs and game consoles, 4oD offers a variety of programs recently shown on Channel 4’s linear channels, Channel 4, E4 and More4, as well as from its archives. Before investing in Aspera On Demand, Channel 4 was delivering content to 4oD via FTP, and wanted to find a way to improve their delivery to viewers. With Aspera On Demand, the broadcaster now benefits from a modern, easy-to-manage solution that’s secure, reliable and speeds up the entire process. Transfer capacity can be scaled-out as needed to meet demand, and the deep integration of the Aspera FASP high-speed protocol with the underlying cloud-based object storage APIs ensures maximum speed end-to-end, while adding key transfer management features such as adaptive bandwidth control, pause, resume and encryption over the wire and at rest. Large collections of small files for “tiled” video formats such as HLS are transferred equally as fast as large video files, and up to 10x faster then typical cloud transfer technologies. As a result, all video content is transferred efficiently and securely from Channel 4’s playout center in West London directly to its cloud object storage in Dublin, Ireland “We decided that Aspera was a mature, fast, reliable and secure solution capable of handling the high volume of video content delivery direct to cloud storage,” said Simon Christie, Broadcast Systems Engineer, Distribution & Broadcast Technology, Channel 4. “The speed, efficiency and reliability that Aspera On Demand provides gives us confidence that every part of the package file is delivered on time and without corruption – which is crucial when we’re updating the platform with a hundred hours of content each week.” Channel 4 was able to easily integrate Aspera On Demand into its existing IT infrastructure. The entire process of transferring content to the cloud is now fully automated, including automated error handling. “Aspera On Demand enables broadcasters to reap the benefits of the cloud by delivering their content directly into the cloud in the fastest, most efficient way possible,” said Michelle Munson, CEO of, Aspera. “With Aspera On Demand, Channel 4 can predictably transfer a greater volume of content to the cloud, enabling them to satisfy growing viewer demand for cross-platform services.” At BVE 2015, in the Broadcast Tech & Workflow Theatre on Tuesday February 24, 10.50-11.20am Channel 4 will give conference attendees more insight on how they accelerated content processing and delivery for their 4oD video-on-demand service with Aspera high-speed transfer and the cloud and attendees can learn more and see demos of all Aspera products at Stand J15.

Alma Media's Financial Statements, the Report by the Board of Directors and the Auditor's report 2014 published

Alma Media Corporation        Stock Exchange Release          24 February 2015 at 11:00 a.m. (EET) ALMA MEDIA'S FINANCIAL STATEMENTS, THE REPORT BY THE BOARD OF DIRECTORS AND THE AUDITOR'S REPORT 2014 PUBLISHED Alma Media has published its Financial Statements, the Report by the Board of Directors and the Auditor's report for the financial year 2014. The document is attached to this release and is also available at www.almamedia.com/investors/financials/financial-reports-and-annual-reviews/. In addition, Alma Media has published today its Corporate Governance Statement. The document is attached to this this release and also available at www.almamedia.com/investors/corporate-governance/corporate-governance-statement/. Alma Media's Annual Review 2015 will be published online during week 11. ALMA MEDIA CORPORATION Juha NuutinenCFO For further information, please contact:Alma Media Corporation, Juha Nuutinen, tel. +358 10 665 3873 Distribution:NASDAQ OMX Helsinki, main media Alma Media is a media company focusing on digital services and publishing. In addition to news services, the company's products provide useful information related to lifestyle, career and business development. The services of Alma Media have expanded from Finland to the Nordic countries, the Baltics and Central Europe. In 2014, the company employed on average 1,830 professionals (excluding deliverers), of whom approximately one fourth worked outside Finland. Alma Media's revenue in 2014 totalled approximately MEUR 295. Alma Media's share is listed on NASDAQ OMX Helsinki. Read more at www.almamedia.com.

Year-End Report - Cinnober Financial Technology AB

· Net sales for the period amounted to SEK 408.4 million. · Profit before tax for the period amounted to SEK 1.8 million.  · Earnings per share before dilution for the period amounted to SEK 0.38.  · A total of 11 new deals during the period – one of a major scale, four of medium scale and six smaller.  · An agreement was signed with the Johannesburg Stock Exchange regarding a major clearing project.  · Strengthened position in relation to banks through the acquisition of the BOAT reporting service.  · The Board proposes that no dividend be paid for the accounting period. · Following the close of the period it was announced that Cinnober will receive more than EUR 2 million for adapting the technology around real-time clearing to cover the needs of European banks.   · Following the close of the period, an agreement was signed for an extensive trading project with the Australian Stock Exchange (ASX), which is one of the world’s ten largest marketplaces. * Following a resolution at an Extraordinary General Meeting on June 26, 2014, the current financial year was extended until December 31, 2014. “In summary, we view the company’s future with great confidence. We enter a new financial year, as the leading independent supplier in our niche globally. Our self-confidence and prospects are strong, particularly given that we consider ourselves to have a product and service portfolio that are completely accurately positioned now that the market looks like regaining momentum.” says Veronica Augustsson, CEO, in a comment. Attachment: Year-End Report July 1, 2013 – December 31, 2014 Cinnober Financial Technology discloses the information provided herein pursuant to the Securities Market Act (Sw. lagen om värdepappersmarknaden). The information was submitted for publication on February 24, 2015 at 11:00 (CET). For further informationVeronica Augustsson, CEO, phone +46 8 503 047 00, veronica.augustsson@cinnober.com Cinnober in brief · Cinnober develops mission-critical system solutions for exchange trading, clearing, risk management and other financial services. · Its target group consists primarily of international exchanges, clearinghouses, banks and brokerages · The company was founded in 1998, currently has approximately 250 employees in Stockholm and Umeå (excluding consultants) representing 29 nationalities · It offers solutions in price discovery, order matching, market data, index calculations, clearing, risk management and market surveillance · The Cinnober share has been listed since September 29, 2014 on NASDAQ OMX First North. Avanza is the Certified Adviser.

Presentation of Nordic Mining's interim report per 31 December 2014

Nordic Mining ASA will present the Q4 2014 interim report and company updates Friday 27 February 2015 at 10.00. The presentation will be held in the company's office at Vika Atrium, Munkedamsveien 45 (Entrance A, 5th floor), N-0250 Oslo.We invite investors, analysts and media to attend the presentation. Kindly give notice of participation by email to post@nordicmining.com or telephone +47-22947790.The interim report will be published at the Oslo Stock Exchange and on Nordic Mining's webpage (www.nordicmining.com) in the morning 27 February 2015.For further information please contact CFO Lars K. Grøndahl, telephone +47-901 60 941.Oslo, 24 February 2015Nordic Mining ASANordic Mining ASA (www.nordicmining.com)Nordic Mining ASA (“Nordic Mining” or “the Company”) is a resource company with focus on high-end industrial minerals and metals in Norway and internationally. The Company’s project portfolio is of high international standard and holds a significant economic potential. The Company’s assets are mainly in the Nordic region.Through the subsidiary Nordic Rutile AS Nordic Mining is undertaking large-scale project development at Engebøfjellet in Sogn and Fjordane where the Company has rights to a substantial eclogite deposit with rutile and garnet. Nordic Mining has rights for exploration and production of high-purity quartz in Kvinnherad in Hordaland and develops the project through its subsidiary Nordic Quartz AS. Nordic Mining’s associated company Keliber Oy in Finland plans to start mining of lithium bearing spodumene and production of lithium carbonate. Nordic Mining holds exploration rights on the Øksfjord Peninsula in Troms and Finnmark, where the Company has discovered a prospective area of sulphide mineralisation. Through the subsidiary Nordic Ocean Resources AS, Nordic Mining is exploring opportunities related to seabed mineral resources.Nordic Mining is listed on Oslo Axess.

Interim Report January – December 2014

FOURTH QUARTER 2014 · Due to the favourable order backlog from the third quarter, sales increased by 5.7% compared with the fourth quarter last year. The pace of the order intake in Q4 was on level with last year´s. Order backlog, excluding the major NYCHA project in the US, was 15% above last year. · The large project in the US with the New York City Housing Authority (NYCHA) ramped up in the fourth quarter but at a lower gross margin than anticipated. Polygon UK continued its preparations to serve two new contracts, which will generate growth in 2015. · Operating profit before amortisation and non-recurring items (EBITA before NRI) amounted to EUR 6.5 million (3.9). The main reasons for the positive deviation are the leverage of increased sales and improved performance from countries that underperformed in previous quarters. Operating profit before amortisation (EBITA) amounted to EUR 5.6 million (loss 4.9). · A new country president was appointed in the Netherlands. At the end of the fourth quarter, it was agreed that the country president in Belgium would step down. The current finance manager is holding the position in the interim. After the closing of the fourth quarter, Luc Hendriks was appointed Chairman of the Board and replaced the previous Chairman. Luc Hendriks joined Triton in 2007 and is currently a Senior Industry Expert at West Park Management Services (WPMS) based in Frankfurt. JANUARY-DECEMBER 2014 · Due to the strong performance at the end of the year, sales were only 0.7% below 2013. Sales increased as the result of rain and flooding in large parts of Europe starting at the end of July and beginning of August, with effects in the fourth quarter. However, the weather conditions on a full-year basis were unfavourable. The number of water-related jobs with higher margins was below last year’s level. · Operating profit before amortisation and non-recurring items (EBITA before NRI) amounted to EUR 13.7 million (14.8). The decrease is mainly in continental Europe. The Nordics and UK performed well the second half of the year. North America was on level with a weak 2013. Operating profit before amortisation (EBITA) amounted to EUR 6.5 million (4.8). Non-recurring items are mainly attributable to management changes and capacity reductions. Group Key FiguresFor Group Key Figures table, please refer to attached file below. Comments from the CEOOur diligent work to get the basics in place is starting to pay off After two challenging quarters that strained profitability, as well as the necessary replacement of local management in several countries, we are now beginning to reap the benefits of our efforts to run a simpler and more consistent business model. The order backlog from the third quarter materialised in the fourth quarter. Compared with last year, we have an improved backlog going into 2015, Otherwise, activity has been low in North America. Europe made a strong comeback after an unfavourable period in spring and early summer. Sales in Germany were slightly below the fourth quarter 2013. In addition to operations in the UK, which continue to grow with favourable results, I am pleased to note the turnaround and the decisive actions that have been taken in countries with underperformance. All of the Nordic countries have experienced a recovery as a result of the actions to improve performance, in addition to more favourable weather conditions. With the exception of Denmark, all country presidents in the Nordic region have been replaced during 2014. Belgium and the Netherlands, which were experiencing serious difficulties, also received new country management and are showing signs of a turnaround. Overall, we improved our profit in the last quarter with more than 60%, closing up the gap versus last year’s profit on a full-year comparison. We are not yet where we should be, but the fourth quarter is clearly a step in the right direction. Restructuring costs and non-recurring items were also significantly lower compared with both the beginning of 2014 and with full year 2013. After the successful bond issue in the second quarter, we have begun to focus again on external growth, primarily low-risk bolt-on targets where we can leverage our structure. We are pleased to have acquired one company in Austria during the fourth quarter and one more in the UK after year-end closing. In Austria we will broaden our scope and offer services to property managers. The acquisition of Harwell in the UK will help us become a leading company in document restoration. By combining Polygon's strong position in document restoration in North America with Harwell's market leadership in Europe, we are well positioned to become the leading global expert in this area, leveraging the respective strengths in the sales and service delivery models of both Polygon and Harwell. A prerequisite for success in a service company with local management is to have a clear framework with models and principles that our managers can use in everyday business. The Polygon Model helps us simplify our business through a clear organisation, consistent service delivery and a well-defined corporate identity and customer segments. The model is based on our core values of integrity, excellence and empathy, which are the heart of everything we do. The model will be launched for approximately 100 managers during the first quarter 2015 and rolled out to the rest of the organisation in subsequent months. I am convinced that this platform will help taking Polygon to the next level. Short term outlookThe current order backlog is approximately equivalent to 1.5 months of sales. Therefore we expect sales in the first quarter to increase compared with last year. Our efforts to improve operational processes together with restructuring activities should lead to positive effects in 2015. Market developmentOur long-term outlook on the property damage restoration market is positive, with weather conditions gradually increasing the damage caused by water, fire, wind and climate change. Part of Polygon’s business is dependent on extraordinary weather conditions. Markets such as the US normally incur several hurricanes each year, with ensuing property damage. The low hurricane levels in 2013 and 2014 impacted Polygon’s business negatively. Net sales and profit for the fourth quarter 2014Consolidated sales for the fourth quarter 2014 amounted to EUR 119.0 million, an increase of 5.7% compared with the same period last year. Sales in the Nordic and UK regions were strong with a growth rate of 7.8%. Europe as a whole showed an increase of 2.5%. North American sales were up by 45.7% due to the NYCHA project. Operating profit before amortisation and non-recurring items (EBITA before NRI) amounted to EUR 6.5 million (3.9). Profitability in the Nordics and UK were up by 23.0% with generally favourable external conditions. Continental Europe increased by 28.5% versus last year, mainly attributable to increased activity in Germany. Profitability in North America improved compared with last year but from a low level. NYCHA brought significant sales to US but at a very low margin. Profits in Canada were improved even considering a decline in sales by -36.7%. Operating profit before amortisation (EBITA) amounted to EUR 5.6 million (loss 4.9). Non-recurring items amounted to a net cost of EUR 0.9 million (8.8). Non-recurring items in the fourth quarter were primarily severance pay in conjunction with restructuring programs and costs related to the legal review in Germany, which was closed in December. The forensic investigation in Germany proved no wrongdoing by Polygon. Based on the findings it was decided to implement an “integrity line” or whistle-blowing function, as well as update and re-launch our Code of Conduct. Net financial expenses for the period amounted to EUR 4.0 million (1.8). Loss before tax for the period amounted to EUR 0.1 million (loss 7.9) and net profit was EUR 1.8 million (loss 4.4). Net sales and profit for January-December 2014Consolidated sales for the full year were EUR 420.2 million, just 0.7% below the same period 2013 after a strong fourth quarter. Sales in Europe decreased by 0.7% and North American sales were also slightly under last year sales, NYCHA compensated a drop in Canadian sales. Operating profit before amortisation and non-recurring items (EBITA before NRI) amounted to EUR 13.7 million (14.8). The leverage from the improved sales in the fourth quarter decreased the gap versus last year to EUR 1.1 million from EUR 3.7 million after Q3. The Nordics and the UK were on par with 2013, while Continental Europe was EUR 0.8 million below last year, mainly due to difficulties in the Netherlands. North America was EUR 0.5 million above last year due to improvements in the US. Operating profit (EBITA) for the Group amounted to EUR 6.5 million (4.8). Non-recurring items totalled EUR 7.1 million (10.0). Non-recurring items are mainly costs for management replacement and capacity reduction in specific areas. Net financial expenses for the period amounted to EUR 11.5 million (12.4). Loss before tax for the period amounted to EUR 10.7 million (loss 13.7) and net loss was EUR 8.5 million (loss 10.5). Cash flow and financingCash flow from operating activities during the fourth quarter of 2014 amounted to EUR 10.3 million (15.8), and cash flow before financing activities amounted to EUR 4.3 million (13.2). Cash flow from operating activities during 2014 amounted to EUR 7.9 million (28.1), and cash flow before financing activities was negative amounting to EUR 4.0 million (positive 21.7). The former bank financing of EUR 103 million was replaced in April with a Senior Secured Floating Rate Note of EUR 120 million which will mature in 2019 and runs with a floating rate of 500 basis points spread over 3 months EURIBOR. The bond was issued by Polygon AB and is granted on a senior level by Polygon Holding AB and selected subsidiaries. Polygon Holding AB has pledged its shares in Polygon AB and Polygon AB has pledged its shares in subsidiaries. In addition to the bond a Revolving Credit Facility Agreement of EUR 14 million was signed which will be used for short-term financing and guarantees. The loan expenses are disclosed in the balance sheet as a reduction from the debt and the costs are allocated in the income statement over the duration of the loan. The loan was listed in December 2014. Total interest-bearing net debt amounted to EUR 101.7 million (December 2013: 89.9). Equity amounted to EUR 44.4 million (December 2013: 53.9). The Group’s liquidity buffer amounted to EUR 31.9 million (December 2013: 17.5), comprising cash and cash equivalents of EUR 21.5 million (December 2013: 15.8) and unutilised contracted loan commitments of EUR 10.4 million. (December 2013: 1.7) Capital expenditureCapital expenditure during 2014 amounted to EUR 12.4 million (8.2). Parent companyThe consolidated figures in the report are presented at the consolidated level of Polygon AB. The parent company, Polygon AB (corporate registration number 556816-5855), directly and indirectly holds 100% of the shares in all subsidiaries in the Group, except for the company in Denmark of which the non-controlled interest is 24.2% Net income for Polygon AB for the fourth quarter amounted to EUR 5.4 million (1.3). Most significant risks and uncertainty factorsThe business carried out by the Group, property damage restoration after events such as flooding and fires, is to some extent dependent on the occurrence of property damage. The frequency of property damage can vary depending on circumstances beyond Polygon’s control, the outdoor temperature and weather. Since part of Polygon’s cost structure is fixed, the proceeds of the operations are to some extent unpredictable and vary from time to time. However the majority of the business (estimated at around 80%) is related to damage independent of weather. Polygon is to a large extent dependent on its key customers, the insurance companies, and must maintain mutually beneficial relationships with them to compete effectively. Our top ten customers comprise about 30% of Polygon´s sales, with the newest customer on the top-ten list representing a seven-year relationship. For further elaboration of the Group’s risk and uncertainty factors, please refer to the 2013 Annual Report. Polygon’s view is that there have not been any significant changes during the reporting period with regards to risks and factors of uncertainty that were presented in the Annual Report. Related-party transactionsThe Group is under the controlling influence of Polygon Holding AB, the Parent Company of Polygon AB. Polygon Holding AB is under the controlling influence of MuHa No2 LuxCo S.á.r.l. There are no material transactions with companies in which MuHa No2 LuxCo S.á.r.l has significant or controlling influence. Accounting policiesThe interim report for the Group has been prepared in accordance with IAS 34 Interim Reporting. The interim report for the Parent Company has been prepared in accordance with the Swedish Annual Accounts Act. The Group applies the International Financial Reporting Standards (IFRS) as adopted by the EU, and the Swedish Annual Accounts Act. The accounting policies applied in this interim report is the same as those applied in the consolidated annual accounts for 2013. More specified accounting policies can be found on page 11-20 in the Annual Report for 2013. A number of standards and changes of standards are in effect from January 1, 2014. Polygon does not intend to apply them beforehand and the overall assessment is that they will have no major impact on the Group’s result or position. The term “IFRS” used in this document comprises the application of IAS and IFRS as well as the interpretation of these standards published by IASB’s Standards Interpretation Committee (SIC) and International Reporting Interpretations Committee (IFRIC). The undersigned assures that this interim report gives a true and valid overview of the Parent Company and the Group’s business, position and results, describing essential risk and uncertainty factors that the Parent Company and its subsidiaries face.   Stockholm, 24 February 2015 Erik-Jan JansenPresident and CEO For more information please contact:Mats Norberg, CFO, + 46 70 331 65 71Email address: ir@polygongroup.com

Bisila Bokoko Embodies The Essence of Modern Girl Power Ahead of International Women’s Day

Ladies across the globe have been quick to embrace a new role model as Bisila Bokoko (http://bbesinternational.com/) continues to inspire, motivate and empower. As a businesswoman, award-winning entrepreneur, philanthropist, motivational speaker, brand ambassador, fashionista and mother, the Afro-Spaniard femme fatale is at the vanguard of a worldwide woman’s movement – and she hopes to inspire even more women throughout March thanks to International Women’s Day. Armed with Master’s degrees in International Relations/Business and Law, Ms Bokoko has built herself a global reputation as a pioneering corporate leader. Throughout her career Bisila Bokoko has established strong global alliance partnerships, built high performance organisations and helped expanding businesses tap into international markets. In a bid to share her expertise, the multilingual businesswoman established Bisila Bokoko Embassy Services International (BBESI) in New York City. The boutique service is underpinned by a goal of bridging the gap between a myriad of international markets including gastronomy, fashion, beauty, lifestyle, arts and culture. The embassy upkeeps a presence in countries across the globe, aiming to open doors, represent international interests and help brands take their business to the next level. Her efforts have won her widespread recognition and led to dynamic involvement in EMPRETEC, a United Nations programme that supports up and coming entrepreneurs. Ms Bokoko fronted the women’s scheme and actively worked to support female entrepreneurs in their efforts to launch hard hitting businesses. “I believe that brains and beauty go hand in hand, with women playing an integral role in the transforming face of modern business,” explains Ms Bokoko.  In 2010 Bokoko branched out into the wine industry and launched an international award-winning eponymous brand made in Spain.  Now esteemed as one of Europe’s finest drops, Bisila Wines is the embodiment of Bokoko’s commitment to success. As well as building an international business empire, Ms Bokoko is also the founder and chairperson of her very own non-profit organisation. With a mission of promoting literacy and a presence in Ghana, Zimbabwe, Kenya and Uganda, the Bisila Bokoko African Literacy Project (http://bbalp.org/) (BBALP) builds modern libraries in an attempt to spread the gifts of knowledge, education and enlightenment throughout the continent. Of course, every woman loves to flaunt a show stopping wardrobe and Ms Bokoko has embedded this passion with a social conscience. Advocating for creativity and sustainable change, Ms Bokoko has won herself places on several prestigious advisory boards including United Colors Of Fashion (http://www.unitedcolorsoffashion.org/) and the Agatha Ruiz de la Prada (http://www.agatharuizdelaprada.com/eng/products) Foundation. Her unique style, impeccable taste and meticulous eye for detail has seen her grace the pages of Harper's Bazaar, The Sunday Times and be featured on Bloomberg TV. In-between juggling career commitments Bokoko’s duty as a mother of two has never wavered. Balancing motherhood with professional endeavours hasn’t been easy but with enough passion, drive and motivation, she maintains that any woman can do it. She explains, “It’s always been my dream to be a catalyst for change. I truly believe that women have so much more to offer and I’m driven by a desire to empower ladies and show them that they can be successful in every aspect of their lives, from business to babies and beyond.” To find out more about Bisila Bokoko visit: BBES International: http://bbesinternational.com  BBALP: http://bbalp.org/ Twitter/ Instagram: @bisilabokoko  https://www.facebook.com/BisilaBokoko For comments or an interview with Ms Bokoko please get in touch using the details below. She is available in London 2-4 March 2015.

Finnair Cargo network grows through strategic partnership with IAG Cargo

Finnair Cargo has signed an agreement to participate in IAG Cargo Partner Plus Program. The Partner Plus is an enhanced version of interline cooperation, which means that through this partnership both IAG Cargo and Finnair are able to deliver enhanced network connectivity to their customers, who will also benefit through confirmed bookings and a higher on-load priority.“This closer cooperation with IAG Cargo will provide our customers better access to many markets beyond our own network. This is an innovative way to grow reach and one that we believe will prove mutually beneficial to IAG Cargo and ourselves," says Juha Järvinen, Chief Commercial Officer, Finnair.Finnair Cargo customers will gain access to markets in South and North America as well as Africa, as the introduction of the IAG network connections offers expanded route availability via London (LHR) and Madrid (MAD). For IAG Cargo the addition of Finnair to the programme will provide additional capacity across the globe, including to Finnair's strategic destinations in North East Asia.“The benefit for customers is clear and with the addition of Finnair we are now able to deliver enhanced connectivity to key destinations through a partner that matches our values of customer service excellence and operational reliability,” says Steve Gunning, CEO of IAG Cargo.In total, six carriers now form the Partner Plus programme including Qatar Airways, Japan Airlines, the Avianca group and American Airlines.Finnair CargoFinnair is the largest Nordic air cargo carrier, transporting 145,000 tonnes of freight and mail annually, with cargo logistics hubs in Helsinki and Brussels as well as an extensive sales team in over 40 countries. Specialized in air cargo traffic between Europe and Asia, Finnair Cargo serves 15 Asian and North American long-haul destinations out of Helsinki, and more than 50 destinations in Europe. With the new A350 aircraft Finnair's long-haul cargo capacity will double by 2020.Finnair Cargo web site: www.finnaircargo.com (http://finnaircargo.fi/)     Finnair Cargo News: news.finnaircargo.com   Finnair Cargo on Twitter: www.twitter.com/FinnairCargo  Mobile site: m.finnaircargo.com/  IAG CargoIAG Cargo is the single business created following the merger of British Airways World Cargo and Iberia Cargo in April 2011. In 2013 the operations of British Airways World Cargo and Iberia Cargo had joint turnover of €1,073 million. They have a combined workforce of more than 2,400 people covering a global network of over 350 destinations.

JCB PUTS ITS TRUST IN MICHELIN’S NEW BIBLOAD HARD SURFACE TYRES

JCB is fitting Michelin’s new BibLoad Hard Surface tyres as original equipment across its extensive range of loadalls, telehandlers and backhoe loaders. Before signing the deal, JCB asked a number of its customers to test the tyres in real-world situations, to ensure they were up to the job. The trials demonstrated the suitability of this new Michelin product, impressing JCB with high levels of damage resistance and impressive handling on rugged surfaces. One of the customers to take part in JCB’s trial was Rob Rawlins, owner/operator of WH & SJ Rawlins, which has two mixed farms in Wiltshire. He tested the BibLoad Hard Surface tyres on a two-year-old JCB 536-70 loadall, which operates across a mix of concrete yards, in the field and on the road, carrying out duties ranging from cattle feeding to spreader loading. The tyres have already completed 500 hours in service, totalling more than 2,500 miles, yet have 29mm of tread remaining out of 33mm. Rawlins says: “The nature of a loadall’s work typically means high tyre wear, so we have been really pleased with how little the BibLoads have worn. They have exceeded all of our expectations; it simply wouldn’t be worth fitting any other tyre to the machine.” Rawlins has also been impressed by the tyres’ outstanding grip, particularly on wet concrete surfaces, where minimal or no wheel spin is experienced. An innovative diamond tread pattern provides an increased contact patch with the ground compared to a standard lugged tyre. This helps to improve resistance to wear, whilst also reducing vibrations and delivering optimum traction. A spokesman for JCB comments: “We were keen to offer a 24” & 26" industrial pattern radial tyre for applications on hard standing ground, so we embarked on the test programme. We expected the improved wear characteristics that were reported, but the positive comments on rough terrain tractive performance and stability were an added benefit and something we’re sure our customers will be quick to take advantage of.” Mike Phillips, Michelin’s Key Account Manager – Original Equipment, explains: “We saw a great opportunity to develop a tyre for these specialist machines that was robust and long-lasting, but which could also be used on the road without wearing too quickly. “The BibLoad’s multidirectional tread blocks, reinforced sidewalls and increased tread depth have enabled us to deliver in all of these areas – it’s something Michelin calls ‘Total Performance’. We are looking forward to hearing how the tyres perform from even more of JCB’s customers.” For more information about the range of Michelin farm tyres available visit www.michelin-agricultural-tyres.co.uk. ends Michelin, the leading tyre company, is dedicated to sustainably improving the mobility of goods and people by manufacturing and marketing tyres for every type of vehicle, including aircraft, automobiles, bicycles/motorcycles, earthmovers, farm equipment and trucks. It also offers electronic mobility support services on ViaMichelin.com and publishes travel guides, hotel and restaurant guides, maps and road atlases. Headquartered in Clermont-Ferrand, France, Michelin is present in more than 170 countries, has 111,200 employees and operates 67 production plants in 17 different countries. The Group has a Technology Centre in charge of research and development with operations in Europe, North America and Asia. (www.michelin.com) For further press information please contact: David Johnson, Michelin Press OfficeTel: + 44 (0) 1782 402341      Email: d.johnson@uk.michelin.com James Keeler or Beth Laws, Garnett Keeler PR, Inver House, 37-39 Pound Street,Carshalton, Surrey, SM5 3PGTel: +44 (0)20 8647 4467   Fax: +44 (0)20 8544 4711   E-mail: james.keeler@garnettkeeler.com or beth.laws@garnettkeeler.com MICHA/116/15

You’re More Likely to be Asked Out on a Dating Site with No Messaging

A forward thinking dating site has unveiled fascinating insight into London’s social scene, with a recent survey revealing that platforms shunning conventional messaging seriously boost the chances of getting asked out. With its revolutionary approach to dating and no messaging policy, Just Ask Me Out (http://www.justaskmeout.co.uk/) is at the forefront of the trend and has quickly emerged as the go-to dating site for Londoners on the search for fast-tracked love. Alex Rowley, Founder of Justaskmeout.com said, “Londoners have spoken and the results of our survey indicate that singles are sick and tired of dating sites that encourage endless back and forth messaging. Rather than spend days, weeks or even months on end wondering who is going to make the first move, Just Ask Me Out revolutionises the dating game and makes sure a face-to-face meet up is organised from the word go.” As part of the survey a group of random Londoners were asked whether or not they agree with the statement “We think the problem with standard messaging on dating sites is people are not sure who is going to ask who out or when and it takes ages to get a date.” A huge 75-80% of respondents agreed that it takes too long to get a date online when using sites that employ standard messaging.  For singletons falling into the 30-39 age bracket signing up for a message free online dating site is a guaranteed way to get a date, fast. This particular demographic displayed the highest level of agreement, with 74% of respondents finding that messaging systems decreased the chances of being asked out. One of the driving forces behind this mindset is the fact that sites without messaging functions cut out the small talk and encourage members to get straight to the point. This means no drawn out virtual flirting, no small talk and no wondering when a love interest is finally going to make the first move. Just Ask Me Out is helping London singles amp up their love lives with a purpose-built platform that shuns the waiting game and gets straight to the point. Rather than waste time messaging back and forth, members send a direct date request to a profile that takes their fancy. It’s quick, simple and refreshingly upfront.  Inviting a crush on a date is amazingly easy and can be done in just a few clicks of the mouse. Members simply find a profile that catches their eye, hit the date request button and enjoy a fabulously straightforward dating experience. The Just Ask Me Out revolution has been recognised by the industry as the website won Best Up & Coming Dating Site 2015 at the iDate Awards in the USA. As more and more Londoners begin to realise the qualms of private messaging Just Ask Me Out is augmenting its reign as the capital’s go-to dating site for fast-moving romance. To watch a video about how Just Ask Me Out works visit: https://www.youtube.com/watch?v=W_xNyttXLI4 To find out more about Just Ask Me Out and shun the tedium of the waiting game for good, visit the website at: www.justaskmeout.co.uk  

Patheon Cincinnati Regional Operations Recognized for Green Business Initiatives

Patheon (http://www.patheon.com/), a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, will be honored as a finalist for the Green Business Award by the Cincinnati Business Courier for its outstanding leadership in sustainable practices, at the Sixth Annual Green Business Awards Program on Thursday, March 5 at 5:30 p.m., at the Sharonville Convention Center in Cincinnati. Patheon is one of several organizations to be honored for sustainable buildings, practices, products and advocacy. “We are thrilled to be recognized for our green development initiatives,” said Nicholas Buschur, executive director and general manager at the Cincinnati site. “Our sustainability practices are in direct support of our commitment to provide customers with industry-leading, innovative solutions.” Patheon’s Cincinnati facility has established a reputation within the community as a leader in sustainable, green initiatives through the use of ecological manufacturing solutions and waste reduction initiatives. The site opened in 2003, in Reading, Ohio, and is dedicated to pharmaceutical development services and manufacturing. More than 600 employees participate in recycling programs, ensuring no materials go to waste, and also maintain a landscaped campus in which grass and debris are composted. Approximately 1,500 tons of solid waste has been diverted from landfills as a result of the Cincinnati site’s recycling and compost programs since 2011. In reflection of Patheon’s commitment to sustainability, the site will continue to evaluate reduction opportunities to further minimize negative impact on the environment.

Mycronic introduces new functionality for next-generation material handling and large board jet printing at IPC APEX

Täby, 24 February, 2015 – Mycronic AB (publ) launches smarter electronic inventory control and large board applications at the IPC APEX trade show on February 24-26 in San Diego, USA. Mycronic´s business areas SMT (Surfact Mount Technology) offers flexible production solutions for electronics manufacturing. The product offering includes production equipment for application of solder paste, robots for mounting electronics components on circuit boards (Pick&place), automated storage solutions and software. Now Mycronic launches new functionality for existing equipment.The new material handling system Agilis Smart Bin builds on the success of the award-winning Agilis feeder concept. Electronic labels are attached directly to the Agilis Smart Bins, used for storage and handling of component reels. These so-called e-labels allow machine operators to receive just-in-time information about material movements, anywhere on the shop floor, thanks to a factory-wide wireless communication link. This reduces manual steps and improves inventory control. Mycronic also extends its jet printing offering with the ability to handle larger boards. This extended capability is often needed in the production of e.g. LED lighting. The new option will extend panel size capacity by 50 percent on the MY600 Jet Printer.Together with the MY200 pick-and-place platform, Mycronic now offers a flexible and versatile total assembly solution for large-board applications. Contacts at Mycronic:Simon SandgrenMarketing Director Business Area SMTTel: +46 8 638 52 00simon.sandgren@mycronic.com Anna UlinderInvestor relationsTel: +46 8 638 52 00anna.ulinder@mycronic.com About Mycronic ABMycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment to the electronics industry. Mycronic headquarters is located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany Japan, Singapore, South Korea, Taiwan, the Netherlands, United Kingdom and the United States. For more information see our web site at: www.mycronic.com  Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR. The information was published on 24 February, 2015.

Asetek Announces Global OEM Purchase Agreement with Fujitsu

February 24, 2015 — Asetek (http://asetek.com/)® announced today a global purchase agreement with Fujitsu Technology Solutions GmbH, a leading global server vendor. Fujitsu will incorporate Asetek’s RackCDU D2C™ liquid cooling technology into its High Performance Computing (HPC) server product line. RackCDU™ enhances Fujitsu’s ability to provide solutions for world-class data center efficiency and reduced operating costs. RackCDU liquid cooling improves data center performance by increasing energy efficiency and server density. Asetek expects Fujitsu to launch the first products based on RackCDU in the second quarter of 2015, and anticipates product launches involving various server models throughout the year. In 2014, Fujitsu was cited by IDC to be the fourth largest server vendor by revenue. “This agreement is a significant milestone for Asetek and its stakeholders,” said André Sloth Eriksen, founder and CEO of Asetek. “Our collaboration with Fujitsu ushers in a new stage in the adoption of RackCDU. With its global reach and industry position, Fujitsu is poised to drive adoption of Asetek liquid cooling in data centers worldwide.” Asetek’s liquid cooling technology provides tangible financial savings for data centers. The typical data center today uses 40% or more of its power for cooling and reducing power consumption is essential to achieving lower data center operating costs. As cited in a study by Lawrence Berkeley National Laboratory, a leading center for energy efficiency research of the US Department of Energy, RackCDU can save over 50% of cooling power and over 21% of total data center energy. Additionally, RackCDU’s ability to increase server density by a factor of 2.5-5x avoids the need for expensive data center build outs. About Asetek Asetek is the world leading provider of energy efficient liquid cooling systems for data centers, servers, workstations, gaming and high performance PCs. Its products are used for reducing power and greenhouse emissions, lowering acoustic noise, and achieving maximum performance by leading OEMs and channel partners around the globe. Asetek’s products are based upon its patented all-in-one liquid cooling technology with more than 2 million liquid cooling units deployed in the field. Founded in 2000, Asetek is headquartered in Denmark with offices in California, China and Taiwan. For more information, visit http://www.asetek.com.  For further information, please contact:Andre S. Eriksen, Chief Executive OfficerMobile: +45 2125 7076, e-mail: ceo@asetek.com

Press release: Nexam Chemical has appointed Christian Svensson as CFO.

Christian Svensson has been Nexam Chemical´s acting CFO since August 2014. He has for the last seven years been self-employed with focus on interim assignments and had e.g. the postion as CFO at NeuroVive Pharmaceutical AB (publ) up until 2013. Prior to that he had several senior positions within the Gambro Group. “We are strengthening the organization by employing Christian Svensson as CFO. Christian has, in an excellent way, taken on the role as CFO for Nexam Chemical as consultant since August 2014. He has an extensive experience of listed companies and companies in the development stage. He will, with his experience of financial processes, bring important competences in the future development in the company. I look forward to continue working together with Christian in the Management Team for Nexam Chemical”, says Anders Spetz, CEO. “I have had the privilege to get to know the company and my new co-workers for a few months and I see good opportunities in the further development of the company. It is inspiring to be part of, and contribute to, the journey that lies ahead for Nexam Chemical”, says Christian Svensson. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Lennart Holm, Chairman of the Board, +46-706 30 85 62, lennart.holm@nexamchemical.com Anders Spetz, CEO, +46-703 47 97 00, anders.spetz@nexamchemical.com

Tele2 pushing for new UN Sustainable Development Goals on anti-corruption

Tele2 is a part of the Swedish network; SLSD, which has about 20 member companies, facilitated by Sida (Swedish International Development Cooperation Agency). The network has made a commitment to individually and collectively work to reduce corruption, and to promote ethical business practices in countries where we operate. Marie Baumgarts, Head of Corporate Responsibility, Tele2 AB, comments: “Since the Millenium Development Goals were launched over a decade ago, we have seen a lot of positive developments. However, within the network we felt that one significant challenge remained; goals regarding corruption. Corruption plays an important part in for example poverty and the discrimination of human rights. So within the network we decided to do something about it. When the original millennium goals were set, companies were practically not a part of the process at all. Today, we sit in the front row and are influential. That is what I call progress!” A specific anti-corruption group, including Tele2 AB and Swedfund amongst others, was created. Together the representatives from the companies drafted a document emphasizing the importance of introducing goals regarding anti-corruption which subsequently went into the proposed post 2015 development agenda as sub goals. The sub goals state that member states of the UN shall “substantially reduce corruption and bribery in all its forms” and “develop effective, accountable and transparent institutions at all levels”. The post 2015 agenda is currently under negotiation and shall be adopted in New York on 25 September this year. Charlotte Petri Gornitzka, Director General of Sida, comments: “The importance of private sector engagement for sustainable global development is increasingly being recognized, in Sweden as well as globally. Companies have great potential to address major challenges such as corruption. Sida is working actively to promote this through different models for private sector collaboration." For more information, please contact: Lars Torstensson, EVP Corporate Communication and Strategy, Tele2 AB, Phone: +46 702 73 48 79. Viktor Wallström, Head of Public Relations, Tele2 AB, Phone: +46 703 63 53 27

Fourth quarter 2014 results

EBITDA amounted to USD 239 (-68) million in the quarter and EBIT was USD -184 (-201) million, after recording a net impairment charge of USD 319 (112) million. Net earnings for the fourth quarter were USD -287 (-56) million, translating into an EPS of USD -1.42 (-0.40). Due to the current challenging macro environment, the company is taking steps to strengthen its business to adapt to market conditions and ensure that the company is in a position to benefit when conditions improve. The company is also working to increase its financial flexibility. The company is considering diversifying its capital structure going forward, as well as aligning loan agreements. “The drop in oil prices and the challenging macro environment are influencing our business and the way we work. In response to this, we have initiated a cost-efficiency programme with an ambition to reduce costs by more than USD 100 million in 2015. Moreover, we are working to increase our financial flexibility and optimize the capital structure. We have constructive dialogues with our banks and stakeholders and we are confident that we will be able to fund our planned developments,” says CEO Karl Johnny Hersvik. Johan SverdrupDuring the quarter, the FEED phase was completed for the Johan Sverdrup development, leading up to submission of the plan for development and operation (PDO) in February 2015. This was a major milestone in the project, confirming the timeline to production start-up in 2019. Following this, Det norske’s P50 reserves have more than doubled. The Ministry of Petroleum and Energy is to conclude on the unitization split. Ivar AasenThe Ivar Aasen project continued to move forward in line with expectations, with construction of the topsides in Singapore and the steel jacket in Sardinia progressing well. Drilling of geo-pilot wells commenced in January 2015.ProductionProduction from the Alvheim fields has been stable and higher than forecast throughout the entire quarter. The production availability for the Alvheim FPSO in the fourth quarter was 99.1 per cent, with a production efficiency of 98.8 per cent, which is above target. The production and processing facility on the Alvheim FPSO was modified in the fourth quarter to receive production from the Bøyla field. First oil was achieved in January 2015, on schedule. Production from Jotun, Jette and Varg has been stable during the quarter, except for a shut in on Jotun for a period in December due to maintenance and upgrades. Atla was shut in for a period in November and December due to maintenance on Heimdal. ExplorationA discovery was made at the Krafla North prospect in the North Sea in December. Following drilling of the Krafla Main appraisal well in early 2015 and further evaluation in the licences, the estimate for recoverable resources was increased to 140-220 million barrels of oil equivalent. Find the Q4 2014 report and presentation attached. The presentation will take place at Felix konferansesenter in Oslo at 08:30 a.m. (CET). A live webcast will be available at our website, www.detnor.no (http://www.detnor.no/en/).

Fourth quarter and year-end report 2014

Fourth quarter compared to the same period 2013 · Net sales decreased by 4 percent to 1,252.0 (1,306.8) MSEK, and by 6 percent at constant FX, with a decline in Norway and higher sales from Sweden and Denmark. · Adjusted*operating income increased to 79.6 (77.0) MSEK, corresponding to an improved margin of 6.4 (5.9) percent. · Adjusted* income for the period increased to 48.1 (16.5) MSEK, and adjusted* earnings per share were 0.80 (0.33) SEK. · Adjusted* operating cash flow improved to 64.5 (-53.2) MSEK. Full year 2014 compared to pro forma 2013 · Net sales increased by 1 percent to 5,267.2 (5,192.4) MSEK, and were flat at constant FX, with strong growth in Sweden and higher sales in Denmark offsetting lower sales in Norway. · Adjusted* operating income decreased to 301.0 (317.2) MSEK corresponding to a margin of 5.7 (6.1) percent, due to the termination of a major contract in Norway as of 1 April 2014. · Adjusted* income for the period increased to 145.1 (89.2) MSEK and adjusted*earnings per share rose to 2.63 (1.78) SEK, positively impacted by lower finance expenses following the refinancing of bank loans in July 2014. · Adjusted* operating cash flow improved to 438.1 (176.1) MSEK, helped by a reduction of inventories compared to an increase in the previous year. · The Board of Directors proposes a dividend for 2014 of 1.30 (-) SEK per share. *) Adjusted for non-comparable items of -6.1 (-19.8) MSEK in operating income in Q4 and -62.5 (-154.3) MSEK   for the full year 2014. For further details on the non-comparable items, see page 4. CEO Statement Net sales for the full year 2014 were slightly up overall, with higher sales in Sweden and Denmark offsetting a decline in Norway following the termination of the ICA Norway contract as of 1 April 2014. Excluding this contract, net sales rose by 7 percent in local currency. The retail market for chicken products in Scandinavia increased by approximately 3 percent* in value for the full year. Group sales increased ahead of the retail market in Sweden and Denmark but behind in Norway. Adjusted operating income and margin for the full year were lower than 2013 pro forma due to the loss of the ICA Norway contract. The impact of the loss of this contract was to a large extent offset by a strong performance in Sweden and operational cost-savings. In the fourth quarter both operating income and margin improved, benefitting from cost-savings and a more favourable inventory position than last year. The refinancing of the bank loans in July at lower interest rates led to significantly lower finance expense. As a result, adjusted income for the period and adjusted earnings per share increased strongly both for the quarter and the full year. Adjusted operating cash flow showed a substantial improvement for the full year, helped by inventory reductions this year compared to increases last year. Net sales in Sweden showed strong growth and the adjusted operating income and margin improved both for the quarter and the full year. In Denmark, net sales and adjusted operating income also increased for both periods. In Norway, the process to replace the sales lost on the ICA Norway contract has taken longer than anticipated. The decline in net sales in Norway was more pronounced in the fourth quarter as the whole retail market for chicken products was affected by extensive media coverage regarding bacteria in chicken. The media focus has continued into 2015 with an ongoing negative impact on demand for chicken products. This, in combination with the loss of the ICA contract, will impact negatively in 2015. In Scandi Standard we go to great lengths to safeguard the healthiness of our products and we believe that chicken products in Norway, as well as in Sweden and Denmark, are among the healthiest in the world. Scandinavian chicken products are generally regarded as being of the highest quality due to the strict standards applied on matters of animal health and welfare and the fact that neither antibiotics nor growth hormones are used in the feed process. Our product innovation programme delivered a number of successful product launches in the year. We will continue to increase our efforts in this area going forward to support our vision of Scandinavians eating chicken at least once more per week. The acquisition of Bosarpskyckling is a valuable addition to the Group in this respect as it creates a new platform for growth in the premium organic segment. We are now looking to increase the number of external farms that are able to supply organic chicken. Our actions to improve operational efficiency continued as planned. The number of chickens processed per employee per day in our main plant in Sweden increased by 26 percent from 2013. In Norway, we managed to reduce operating costs but the number of chickens processed per employee and day declined by 16 percent because of the sharp fall in sales volumes. The lower cost base creates a good platform for improved efficiency in production going forward. We made good progress in many areas during 2014 and strengthened our position as the market leader in chicken-based food products in Scandinavia. The adjusted operating income for the Group was below our initial expectations due to the decline in sales in Norway, but this has not caused us to change our medium-term financial targets communicated in June 2014. Leif Bergvall HansenManaging Director and CEO For further information, please contact: Leif Bergvall Hansen, Chief Executive Officer,   Tel: +45 22 10 05 44Jonathan Mason, Chief Financial Officer,           Tel: +45 22 77 86 18Patrik Linzenbold, Head of Investor Relations, Tel: +46 708 25 26 30This interim report comprises information which Scandi Standard is required to disclose under the Securities Markets Act and/or the Financial Instruments Trading Act. It was released for publication at 07:30 CET on 25 February 2015.

ASETEK – Ex Subsequent Offering today 25 February 2015

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES Oslo, 25 February 2015 Reference is made to the stock exchange notice published by Asetek A/S (the “Company”, ticker "ASETEK") today regarding the completed Private Placement. The Company’s shares will trade exclusive the right to participate in the subsequent offering from and including today, 25 February 2015. Important information: The release is not for publication or distribution, in whole or in part directly or indirectly, in or into Australia, Canada, Japan or the United States (including its territories and possessions, any state of the United States and the District of Columbia). This release is an announcement issued pursuant to legal information obligations, and is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. It is issued for information purposes only, and does not constitute or form part of any offer or solicitation to purchase or subscribe for securities, in the United States or in any other jurisdiction. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act. The Company does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in the United States. Copies of this announcement are not being made and may not be distributed or sent into Australia, Canada, Japan or the United States. The issue, exercise, purchase or sale of subscription rights and the subscription or purchase of shares in the Company are subject to specific legal or regulatory restrictions in certain jurisdictions. Neither the Company nor the Managers assume any responsibility in the event there is a violation by any person of such restrictions. The distribution of this release may in certain jurisdictions be restricted by law. Persons into whose possession this release comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. Arctic and Carnegie are acting for the Company and no one else in connection with the Private Placement and the Subsequent Offering and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients or for providing advice in relation to the Private Placement and the Subsequent Offering and/or any other matter referred to in this release. Forward-looking statements: This release and any materials distributed in connection with this release may contain certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the Company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. ***

ASETEK – Q4 2014: Building momentum within data center liquid cooling

February 25, 2015 – Total revenues for 2014 were $20.8 million, on par with 2013. Fourth quarter revenues were $4.6 million, versus $6.1 million the same period last year. Asetek expects strong quarter-on-quarter revenue growth for the first and second quarter of 2015, mainly driven by the release of its Generation 5 platform of products. During 2014, Asetek continued to invest in its growth strategy targeting large-scale adoption of liquid cooling of data centers. In February 2015, The California Energy Commission selected Asetek for a $3.5 million project to install RackCDU liquid cooling in two data centers. Yesterday, Asetek announced a global OEM purchase agreement with Fujitsu. Fujitsu will incorporate Asetek’s RackCDU liquid cooling technology into its high performance computing server product line and is expected to launch the first products in the second quarter of 2015. Intellectual property is a key part of Asetek’s growth platform. In December 2014, the U.S. District Court unanimously ruled in favor of Asetek on all claims in its patent infringement lawsuit against CMI USA, Inc and in February 2015, the patent case with CoolIT Systems Inc. (“CoolIT”) was settled. “We spent 2014 building momentum with continued data center and IP investments, and achieved progress with existing and potential partners. We are very pleased that our strategic efforts over the last couple of years are yielding results. When we now strengthen our balance sheet, we are preparing for accelerated growth with data center volume ramp-up and further partnering with top tier OEMs”said André Sloth Eriksen, founder and CEO of Asetek. Fourth quarter material The fourth quarter report and the webcast presentation are attached to this release and available from the company’s website www.asetek.com. WebcastAsetek will give a presentation today at 08:30 CET which can be followed through a webcast or a conference call. CEO André Eriksen and CFO Peter Dam Madsen will represent the company. A link to the webcast can be accessed from asetek.com/investor-relations/reports-presentations. The conference call details are: +----------------------------------+-------------------+|Oslo, Norway |+47 2350 0486 |+----------------------------------+-------------------+|Copenhagen, Denmark |+45 32 71 16 59 |+----------------------------------+-------------------+|London, United Kingdom |+44 (0)20 3427 1915|+----------------------------------+-------------------+|New York, United States of America|+1 646 254 3367 |+----------------------------------+-------------------+| | |+----------------------------------+-------------------+|Confirmation Code: |7385201 |+----------------------------------+-------------------+ Q&A The conference call lines will be opened for participants to ask questions at the end of the presentation. For further information, please contact:Andre S. Eriksen, Chief Executive OfficerMobile: +1 408 398 7437, e-mail: ceo@asetek.com Peter Dam Madsen, Chief Financial OfficerMobile: +1 408 813 4147, e-mail: investor.relations@asetek.com

Cecilia Lager and Anna Settman nominated to Eniro’s Board of Directors

Cecilia Lager and Anna Settman will strengthen the Board of Eniro with additional competence and experience in digital products and services as well as in business and financial control. “As Chair of Eniro’s Nomination Committee, I am happy to nominate Cecilia Lager and Anna Settman as directors on Eniro’s board. Their experience is a good fit with the competence that Eniro’s board has today, and with these two new members the new board will have a favorable composition for Eniro’s continued development,” comments Ulric Grönvall, Nomination Committee chair. Cecilia Lager (born 1963) currently serves as a director on several companies’ boards. Her board assignments are in both listed and unlisted companies, such as Elanders AB, Knowit AB, Cinnober Financial Technology AB, Altor Fund Manager AB and Navigera AB. Cecilia Lager has many years of experience from strategic change processes, marketing and communications, and from the finance sector, and has held senior positions for Alecta, SEB and ABB, among others. Anna Settman (born 1970) has extensive experience from the media and communication industry, with 15 years in the management of Aftonbladet Hierta, three of which as CEO. Sheis also a former member of the executive management of Schibsted Sverige. Anna is currently a founding partner of The Springfield Project, a newly established accelerator for Swedishstart-ups. Anna Settman has experience from board assignments in both listed and unlisted companies and is currently engaged in Nordnet Bank, Hyper Island and Anticimex, among others.

ASSA ABLOY acquires MSL in Switzerland

ASSA ABLOY has signed an agreement to acquire MSL Schloss und Beschlägefabrik AG, a leading Swiss supplier of innovative locks. "I am very pleased to welcome MSL into the ASSA ABLOY Group. This acquisition delivers on our strategy to strengthen our position in the mature markets through adding complementary market segments and products", said Johan Molin, President and CEO of ASSA ABLOY. "MSL stands for innovative lock technology", said Tzachi Wiesenfeld, Executive Vice President of ASSA ABLOY and head of the EMEA division. “It has continually shown its success thanks to its high product quality and competent and dedicated employees. MSL will fill in a gap in our product portfolio in the important Swiss market, making ASSA ABLOY more relevant to our Swiss distributors.” MSL was founded in 1892 and has 106 employees. Its head office and factory is located in Kleinlützel near Basel, Switzerland. Sales for 2015 are expected to reach CHF 20 M (approx. SEK 180 M) in the financial year ending 30 June 2015. The acquisition will be accretive to EPS from start. The transaction is expected to close during Q2 2015. For more information, please contact:Johan Molin, President and CEO, tel no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel no: +46 8 506 485 72 About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end-user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 44,000 employees, operations in more than 70 countries and sales close to SEK 57 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, door automation and hotel security.

Notice to attend the Annual General Meeting

PROPOSED AGENDA 1.     Opening of the meeting.2.     Election of chair of the meeting.3.     Preparation and approval of voting register.4.     Adoption of agenda.5.     Election of two persons to check the minutes of the meeting.6.     Determination of whether the meeting has been duly convened.7.     Speech by the CEO.8.     A description by the chair of the Board of Directors of the work of the Board of Directors and the board committees during 2014.9.     Presentation of the annual report, the auditor’s report, the consolidated financial statements and the auditor’s report on the consolidated financial statements for 2014.10.  Resolution on: a)    adoption of the income statement and balance sheet, as well as the consolidated income statement and the consolidated balance sheet for 2014, b)    appropriation of the Company’s result as shown on the adopted balance sheet and setting of record date for the dividend, c)    discharge of the directors and the CEO from personal liability towards the Company for the administration of the Company in 2014. 11.  Resolution on number of directors and alternate directors to be elected at the meeting.12.  Resolution on remuneration payable to the directors.13.  Election of chair of the Board of Directors, directors and any alternate directors.14.  Resolution on number of auditors and deputy auditors.15.  Resolution on remuneration payable to the auditor.16.  Election of auditor and any deputy auditors.17.  Resolution regarding the nomination committee.18.  Resolution on guidelines for remuneration to senior executives.19.  Shareholder’s proposal regarding split of Eniro.20.  Closing of the meeting.   A complete version of the notice is available in the attached document. The English text is an unofficial translation of the Swedish original. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

The first order for a mask writer based on Mycronic´s replacement strategy

Täby, 25 February, 2015 – Mycronic AB (publ) has received an order for a mask writer replacing an older system for manufacturing of display photomasks from a customer in Asia. It is estimatedthat the system will be delivered during the first half of 2016. Mycronic offers mask writers for the manufacturing of photomasks within different fields of application. These areas are display manufacturing (for TV, smart phones and tablets among other things) and applications within the multi-purpose market, a broad segment comprising many different application areas.Ever since the mid 1990s, Mycronic has been delivering mask writers for production of photomasks that are necessary in the manufacturing process for all flat screen displays. Mycronic occupies a unique position as the only supplier in the world of equipment for manufacturing of advanced photomasks. Since the year 2000, Mycronic has delivered approximately 65 mask writers for display applications. A little more than half of these are 10 or more years old. Maintaining these systems is increasingly a challenge. Some of Mycronic's customers with older mask writers also need to modernize their production equipment. To offer customers a wider choice, Mycronic has established a replacement strategy to address the needs described above. Mycronic offers a scalable system, built on the Prexision platform, in exchange for an older system. This offering allows customers to increase productivity. At the same time a long-term service solution is secured for the customer.”This is the first mask writer we are delivering to a customer in exchange for one of their older systems. The mask writer is scalable, which provides the customer with the possibility to further upgrade the mask writer later on,” says Magnus Råberg, Senior VP & General Manager for business area PG at Mycronic AB. “It is gratifying to present an offering that addresses several of the challenges that our customers are facing." The price level for a replacement mask writer built on the Prexision platform is normally in the range of USD 12–16 million depending on the configuration and type of machine traded in. Contacts at Mycronic: Contacts at Mycronic:Magnus RåbergSr VP & General Manager PGTel: +46 8 638 52 00magnus.raberg@mycronic.comPer EkstedtCFOTel: +46 8 638 52 00per.ekstedt@mycronic.com About Mycronic ABMycronic AB is a Swedish high-tech company engaged in the development, manufacture and marketing of production equipment to the electronics industry. Mycronic headquarters is located in Täby, north of Stockholm and the Group has subsidiaries in China, France, Germany Japan, Singapore, South Korea, Taiwan, the Netherlands, United Kingdom and the United States. For more information see our web site at: www.mycronic.com  Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR. Mycronic is publishing this information in accordance with the Financial Instruments trading Act and/or the Swedish Securities Markets Act. The information was submitted for publication on 25 February, 2015, at 08.00.

Nexam Chemical Holding AB (publ) Year-End Report 1 January – 31 December 2014

Operations: ·As of 1 January 2015 Anders Spetz has been appointed new CEO of Nexam Chemical. ·NEXIMID® MHT-R, a new resin for high temperature applications, has been launched. ·NEXAMITE® PBO, a multifunctional additive, has been introduced on the market. ·Nexam Chemical and BASF have jointly decided not to extend the exclusivity agreement which expires in May 2015. This enables Nexam Chemical to collaborate with other partners regarding nylon-66. ·The exclusivity agreement with Armacell has been extended after delays in the developing process. This is a result of a strategic decision made by Armacell to switch over to recycled PET. ·The rPET project, partly financed by Eurostar, began during the quarter as a collaboration with Armacell and The European Van Company. The aim of the projcect is to develop a product that can help PET and recycled PET to be upgraded for use in, e.g. sandwich composites for production of vehicle bodies. Financial & legal: ·Net sales for the fourth quarter totalled SEK 642,000 (1,707,000). Profit/loss before tax for the period amounted to SEK -10,446,000 (-8,126,000). ·Total assets at the end of the period amounted to SEK 84,880,000 (54,516,000), with cash and cash equivalents accounting for SEK 62,543,000 (32,511,000). ·The net cash flow for the fourth quarter was SEK -8,961,000 (-7,172,000). Key events after end of the period ·The Management and key persons in the company has subscribed for a total of 700,000 warrants. ·Christian Svensson, acting CFO since August 2014, has been employed. ·Two new patents has been approved. In the US, for a new process of manufacturing EBPA and in Europe for catalysis of crosslinking. Lund, 25 February 2015Board of Directors These financial statements have not been audited by the Company's auditor.  This Year-End Report is published in Swedish and English. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact:Lennart Holm, Chairman of the Board: +46 (0)706 30 8562Anders Spetz, CEO, +46 (0)703 47 97 00

Notice of Annual General Meeting of NeuroVive Pharmaceutical AB (publ)

Read notice in pdf: Notice of General Meeting eng (http://mb.cision.com/Public/6574/9730098/891531a903ed4d99.pdf) Entitlement to participate and notificationShareholders that wish to participate at the Annual General Meeting should• be included in the share register maintained by Euroclear Sweden AB on Tuesday 24 March 2015, and• notify the Company in writing by no later than Tuesday, 24 March 2015 to NeuroVive Pharmaceutical AB, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden. Such notification is also possible by telephone +46 (0)46 275 6220 or fax +46 (0)46 888 8348 or by email: info@neurovive.com. Notifications must state full names, personal or corporate identity numbers, shareholdings, address, daytime telephone number, and where applicable, information on deputies or assistants (maximum of two). Where applicable, notifications should also enclose powers of attorney, certificates of registration and other legitimacy papers. Nominee-registered sharesFor entitlement to participate at the Annual General Meeting, shareholders with nominee-registered holdings with banks or other administrators must temporarily re-register their shares in their own name with Euroclear Sweden AB. Such re-registration must be complete by no later than Tuesday, 24 March 2015, which means that shareholders that wish to conduct such re-registration must inform their administrator thereof in good time prior to the aforementioned date.Proxies etc.If shareholders attend by proxy, such proxy must bring a written power of attorney, dated and signed by the shareholder to the Meeting. This power of attorney may not be older than one year, unless a longer term of validity (although subject to a maximum of five years) is stated in the power of attorney. If the power of attorney has been issued by a legal entity, the proxy should also bring the relevant certificate of registration or corresponding legitimacy papers for the legal entity. To facilitate entry, a copy of the power of attorney and other legitimacy papers should be attached to the notification of attendance of the Meeting. Power of attorney forms are available from the Company’s website www.neurovive.se and can be sent by mail to shareholders that contact the Company stating their mail address. Number of shares and votes At the time of publication of this Notice, the total number of shares and votes of the Company is 27,788,093. Additionally, 1,300,000 shares have been subscribed and allocated in the company's recently completed private placement. The Company does not hold any treasury shares. Proposed agenda:0. Opening the Meeting.1. Election of a Chairman of the Meeting.2. Preparation and approval of the voting list.3. Approval of the agenda.4. Election or two persons to verify the minutes.5. Consideration of whether the Meeting has been duly convened.6. Chief Executive Officer's address.7. Submission of the Annual Accounts and Audit Report and the Consolidated Accounts and Consolidated Audit Report.8. Resolutions a) On adopting the Income Statement and Balance Sheet and the Consolidated Income Statement and Consolidated Balance Sheet. b) On appropriation of the Company's earnings in accordance with the adopted Balance Sheet. c) On discharging the Board members and Chief Executive Officer from liability.9. Determination of the number of Board members10. Determination of Directors' and audit fees.11. Election of a Board of Directors.12. Resolution on guidelines for remuneration to senior executives.13. Resolution on guidelines for the Nomination Committee.14. Resolution on authorizing the Board of Directors to decide on the new issue of shares. 15. Closing the Meeting. Proposed resolutions in brief: Election of a Chairman of the Meeting (point 1)The Nomination Committee proposes that the Annual General Meeting appoints Andreas Sandgren as Chairman of the Meeting. Appropriation of profits (point 8 b)The Board of Directors proposes that the Annual General Meeting disposes over the Company’s earnings in accordance with the Board of Directors’ proposal in the Annual Accounts. Additionally, the Board of Directors proposes that no dividend is paid for the financial year 2014.Determination of the number of Board members and determination of Directors’ and audit fees (point 9 and 10)The Nomination Committee proposes that the Annual General Meeting resolves that the number of Board members shall be eight. The Nomination Committee also proposes that fees to Board members elected by the Annual General Meeting not employed by the Company and members of the Board of Directors’ various Committees not employed by the Company shall be payable as follows: • SEK 300,000 to the Chairman of the Board;• SEK 150,000 each to other Board members;• SEK 100,000 to the Chairman of the Audit Committee;• SEK 50,000 each to other members of the Audit Committee;• SEK 40,000 to the Chairman of the Remuneration Committee;• SEK 20,000 each to other members of the Remuneration Committee. Having considered the Company’s and the Board of Directors’ appraisal of the auditors’ work, the Nomination Committee proposes that as in the previous year, audit fees should be in accordance with approved account pursuant to customary billing terms. No fees shall be payable to members of the Nomination Committee. Election of the Board of Directors (point 11)The Nomination Committee proposes that the Annual General Meeting approves re-election of the following Board members: Greg Batcheller, Arne Ferstad, Boel Flodgren, Marcus Keep, Helena Levander, Anna Malm Bernsten and Helmuth von Moltke. The Nomination Committee also proposes the election of Fredrik Olsson as a Board member. The Nomination Committee proposes that Greg Batcheller is re-elected as Chairman of the Board.Resolution on guidelines for remuneration to senior executives (point 12)The Board of Directors proposes that the Annual General Meeting approves the following guidelines for senior executives:Guidelines for remuneration and other employment terms for management primarily imply that the Company should offer its senior executives market remuneration, that the remuneration shall be subject to consultation by a dedicated Remuneration Committee within the Board of Directors, that the associated criteria shall constitute the senior executive’s responsibilities, role, competence and position. Remuneration to senior executives decided by the Board of Directors excluding any Board members affiliated to the Company and management. The guidelines shall be applied to new agreements, or existing agreements reached between senior executives after the guidelines have been adopted, and until new or revised guidelines are determined. What is stipulated for NeuroVive also applies to the Group, where applicable. This proposal is basically identical to the guidelines approved for remuneration to senior executives in the previous year. 1. Basic principleSalary and other benefits, as well as any share-related incentive programs, shall be on market terms and shall be structured so that NeuroVive can attract and retain competent senior executives. 2. Fixed compensationSenior executives shall be offered fixed compensation that is on market terms and based on the senior executive's responsibilities, roll, competence and position. Fixed compensation shall be subject to annual review. 3. Variable remunerationFrom time to time, senior executives may be offered variable remuneration. Such variable remuneration shall be on market terms and shall be based on the outcome of predetermined financial and individual targets. The terms and conditions and basis of computation of variable remuneration shall be determined for each financial year. Variable compensation is settled in the year after vesting and may either be paid as salary or as a lump-sum pension premium. Payment as a lump-sum pension premium is subject to indexation so the total cost for NeuroVive is neutral. The basic principle is that the yearly variable remuneration portion may amount to a maximum of 30% of fixed annual compensation. The total of the variable remuneration for senior executives may amount to a total maximum of SEK 1,500,000. When structuring variable remuneration that is payable to management in cash, the Board of Directors should consider introducing provisions such as: a.) making payment of a predetermined portion of such remuneration conditional so the performance on which vesting is based is demonstrably sustainable over time, andb.) offers the Company the opportunity to reclaim such remuneration paid on the basis of information that subsequently proves manifestly erroneous. 4. Non-monetary benefitsWhere the Board of Directors considers it appropriate and/or after individual consideration of an overall salary and benefits structure, a senior executive may be entitled to additional healthcare insurance. 5. PensionSenior executives are entitled to market-based pension solutions in accordance with collective bargaining agreements and/or agreements with NeuroVive. All pension obligations should be defined contribution. Salary waivers may be utilized to increase pension provisions through lump-sum pension premiums, providing the total cost for NeuroVive is neutral. 6. Notice periodFrom NeuroVive’s side, the maximum notice period shall be six months for the Chief Executive Officer and a maximum of six months for other senior executives. The notice period from the Chief Executive Officer’s side shall be a minimum of six months, and from other senior executives’ side, shall be a minimum of three months. 7. The consultative and decision-making process of the Board of DirectorsThe Board of Directors' Remuneration Committee consults on proposals for decision regarding salary and other employment terms for senior executives. Remuneration to senior executives is then decided by the Board of Directors, excluding any Board members who are affiliated to the Company and its management. Share-related incentive programs approved by shareholders’ meetingsThrough its Nomination Committee, the Board of Directors shall consider the need for share-related incentive programs yearly, and where necessary, submit a proposal for resolution to the Annual General Meeting regarding a well-considered share-related incentive program for senior executives and/or other employees. Resolutions regarding any share and share price-related incentive programs targeted at senior executives shall be made by shareholders’ meetings. 8. Information on previously approved remuneration that is not due for paymentThere is no previously approved remuneration that is not due for payment. 9. Information on departure from the guidelines resolved by the Annual General MeetingThere have been no departures from previously approved guidelines. 10. OtherThe Board of Directors shall be entitled to depart from the above guidelines if the Board of Directors judges that there are special circumstances justifying this in an individual case. Resolution on the guidelines for the Nomination Committee (point 13) The Nomination Committee proposes that the work of the Nomination Committee for the Annual General Meeting 2016 should be conducted as follows: • The Company shall have a Nomination Committee that shall consist of a member for each of the three largest shareholders in terms of votes, based on the shareholder statistics as of 30 June 2015, which the Company obtains from Euroclear Sweden AB. If such shareholder does not exercise its right to appoint a member, the right to appoint a member of the Nomination Committee shall transfer to the next largest shareholder in terms of votes. Coincident with the appointment of a new Nomination Committee, in an appropriate manner, the Chairman of the Board shall contact the three largest shareholders identified and request them to nominate the person said shareholder intends to appoint as a member of the Nomination Committee in writing within a reasonable period in the circumstances, although not exceeding 30 days. The majority of the Nomination Committee's members should be non-affiliated to the Company and its management. The Chief Executive Officer or other member of management should not be a member of the Nomination Committee. At least one of the members of the Nomination Committee should be non-affiliated to the largest shareholder of the Company in terms of votes, or group of shareholders that cooperate on the Company’s administration. Board members may be members of the Nomination Committee, but should not constitute a majority of Nomination Committee members. The Chairman of the Board or other Board members should not be the Chairman of the Nomination Committee. If more than one member is a member of the Nomination Committee, a maximum of one of these people should be affiliated to the Company’s largest shareholder. Information on the definitively appointed Nomination Committee shall include the name of the three appointed members, as well as the name of those shareholders that appointed them, and shall be published by no later than six months prior to the scheduled Annual General Meeting. The Nomination Committee’s term of office extends until a new Nomination Committee has been appointed. Unless the members agree otherwise, the chairman of the Nomination Committee should be that member appointed by the largest shareholder in terms of votes. • If one or more of the shareholders that have appointed members of the Nomination Committee are no longer one of the three largest shareholders in terms of votes, members appointed by such shareholders shall put their places on the Nomination Committee at the Committee’s disposal, and that, or those, shareholders that have become one of the three largest shareholders in terms of the vote shall be entitled to appoint members. However, unless there are special circumstances, there shall be no changes to the composition of the Nomination Committee if only marginal changes to the number of votes have occurred, or any such change occurs later than two months prior to the Annual General Meeting. Shareholders that have appointed members of the Nomination Committee are entitled to dismiss such member, and appoint a new member of the Nomination Committee if the member appointed by said shareholder decides to leave the Nomination Committee. Changes to the composition of the Nomination Committee shall be published as soon as they have occurred. • The Nomination Committee shall prepare proposals on the following issues to be submitted to the Annual General Meeting for resolution: a) a proposal regarding a Chairman of the Meeting;b) a proposal regarding the number of Board members elected by the Annual General Meeting, and where applicable, the number of auditors;c) a proposal regarding fees to Board members not employed by the Company, and members of the Board’s various Committees not employed by the Company;d) a proposal regarding audit fees;e) a proposal regarding election of the Chairman of the Board and other Board members, and where applicable, election of auditors;f) a proposal regarding guidelines for appointing members of the Nomination Committee, and for the duties of the Nomination Committee;g) a proposal regarding fees to members of the Nomination Committee. Resolution on authorization for the Board of Directors to decide on the new issue of shares (point 14)The Board of Directors proposes that the Annual General Meeting resolves to authorize the Board of Directors to decide on the new issue of shares, with or without waiving the preferential rights of shareholders on one or more occasions in the period until the next Annual General Meeting.The number of shares issued through this authorization may correspond to an increase of share capital of a maximum of fifteen per cent (15%) based on the total share capital of the Company at the time of the Annual General Meeting 2015. Share issues should be at market subscription price, subject to reservation for a market discount where applicable, and apart from cash, payment may be as assets contributed in kind or through offset or subject to other terms and conditions. A new share issue decided with this authorization should be conducted with the aim of raising working capital for the Company. If the Board of Directors decides on a share issue waiving shareholders' preferential rights, the reason should be to raise working capital for the Company and/or for new owners of strategic significance to the Company and/or acquisitions of other companies or operations. For validity, resolutions require the proposal to be supported by shareholders representing at least two-thirds of the votes cast and shares represented at the Meeting.OtherThe Annual Accounts and Audit Report of the Company and Group, as well as complete proposals for resolution and the auditor's statement pursuant to chap. 8, § 54 of the Swedish Companies Act, will be available at the Company's offices, Medicon Village, Scheelevägen 2, Lund, Sweden, and at the Company’s website www.neurovive.se by no later than three weeks prior to the Annual General Meeting, and will be sent to those shareholders that so request and state their mail address. Shareholders attending the Annual General Meeting are entitled to request disclosures regarding matters on the agenda or the Company’s or Group’s financial position in accordance with chap. 7 § 32 of the Swedish Companies Act (2005:551) THE BOARD OF DIRECTORSNeuroVive Pharmaceutical AB (publ)Lund, Sweden, February 2015 N.B. English translation is for convenience purposes only. NeuroVive Pharmaceutical AB (publ) is required to publish the information in this news release under The Swedish Securities Market Act. The information was submitted for publication on 25 February 2015, at 8:30 a.m. CET.

Martina Merz and Eckhard Cordes proposed as new Board members of AB Volvo

Martina Merz, 51, recently relinquished her position as CEO of the global brake manufacturer Chassis Brakes International. Prior to that, she worked for nearly 25 years with Robert Bosch GmbH, most recently as head of marketing and sales at the Chassis System Brakes division. Martina Merz has long experience of the automotive industry and is currently a member of the Board of SAF Holland S.A, a subcontractor to the truck and bus industry. She holds a BS in mechanical engineering from the University of Cooperative Education in Stuttgart. Eckhard Cordes, 64, has devoted most of his active professional life to the automotive industry. For nearly 30 years, he has held a number of management positions with Daimler Benz, including head of the company’s truck and bus operations. Eckhard Cordes has also been a member of several boards of directors, including Air Berlin, SKF, Carl Zeiss and Rheinmetall AG. He is currently Chairman of the Board of the industrial group Bilfinger SE. Eckhard Cordes is a partner in Cevian Capital and EMERAM Capital Partners. He holds a PhD and an MBA from the University of Hamburg. The Election Committee of AB Volvo comprises the Chairman of the Board and four representatives of the company’s largest owners, who together represent 22.4% of the shares and 46.7% of the votes. The members who represent the largest owners are Carl-Olof By, representative of AB Industrivärden, Lars Förberg, representative of Cevian Capital, Yngve Slyngstad, representative of Norges Bank Investment Management and Håkan Sandberg, representative of Svenska Handelsbanken, SHB Pension Fund, SHB Employee Fund, SHB Pensionskassa and Oktogonen. For further information, please contact: Carl-Olof By, Chairman of the Election Committee, telephone +46 (0)8-666 64 00. For more news from the Volvo Group, please visit http://www.volvogroup.com/globalnews. The Volvo Group is one of the world’s leading manufacturers of trucks, buses, construction equipment and marine and industrial engines. The Group also provides complete solutions for financing and service. The Volvo Group, which employs about 100,000 people, has production facilities in 19 countries and sells its products in more than 190 markets. In 2014 the Volvo Group’s sales amounted to about SEK 283 billion and is listed on Nasdaq Stockholm. For more information, please visit www.volvogroup.com or www.volvogroup.mobi if you are using your mobile phone. AB Volvo (publ) may be required to disclose the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication at 08.30 a.m February 25, 2015.

Holmen reduces carbon dioxide emissions by 45 per cent

The investment in a new recovery boiler at the paperboard mill in Iggesund has significantly reduced emissions of fossil carbon dioxide and the target is to become self-sufficient in heating and electricity. As a result of extensive energy investments the paperboard mill in Workington currently runs on biofuel and is self-sufficient in electricity and thermal energy. In addition, fossil-free electricity is distributed to the local community. Today, the manufacture of paperboard in the Holmen Group is virtually fossil-free. Major investments have been made at Hallsta Paper Mill to increase its energy efficiency, mainly through increased heat recovery from paper machines and pulp production. During 2014, emissions of fossil carbon dioxide decreased by around 70 per cent compared with 2013. At Braviken Paper Mill, oil consumption has decreased due to improvements in the operational strategy for the mill’s steam system, greater efficiency in the solid fuel boiler and increased steam recovery from the production of thermo-mechanical pulp. Together these measures have allowed Holmen to reduce emissions of fossil carbon dioxide by 45 per cent in 2014, from 123 to 67 kilos per tonne of paper and paperboard products produced, compared with 2013. In recent years Holmen has received several awards for its sustainability work and is included in the UN’s global stock index Global Compact 100 for companies that show a strong financial performance combined with sustainable operations. During 2014 Holmen also gained a place in the Carbon Disclosure Projects (CDP) list of 187 listed companies that are pioneers in the fight against the threat of climate change. In January 2015 Holmen was also named by CDP as one of the 121 best suppliers in the world as regards action against climate change. Lars Strömberg, Holmen’s director of sustainable and environmental affairs comments:“Our strategy of investing in fossil-free technology at the mills in Sweden and the UK has been crucial for our sustainability work and we are very satisfied with the results for 2014. Being recognised with awards and being included in the sustainability index is acknowledgement of our work. Our efforts on energy and climate issues also create trust, which strengthens our brand with regard to investors, customers and suppliers.” For further information, please contact:Ingela Carlsson, communications director, Holmen, tel. +46 (0)70-212 97 12

JustoCat - robotic therapy cat for people with dementia and intellectual disabilities

The functions of JustoCat makes it resemble a live cat. It breathes, purrs and meows. One advantage with the cat's fur is that it is washable and above all is removable and thus can meet hygiene requirements in an institution. JustoCat can provide peace, be soothing and be a tool for increased interaction and communication. It is a complement in the care of people with dementia and in the care of people with intellectual disabilities. Tests and research demonstrates positive results from the users, as well as patients / clients and care-givers. - The goal of JustoCat is to enrich the daily lives of people with dementia. It can provide increased psychological, physical and social well-being, says Lars Asplund, creator of JustoCat. A preliminary study made by the researcher Marcus Persson at Mälardalen University also shows the positive impact of the psychosocial work environment for health care personnel. JustoCat is now available on the European market, both for sale and through leasing, via the company Robyn Robotics AB operated by the two innovators / researchers at Mälardalen University, Lars Asplund and Christine Gustafsson. Several units have already been sold to a number of health and social care operators in Sweden and Europe. Robotdalen has participated in and contributed to the development of JustoCat. - JustoCat is a product that provides an improved quality of life, which is the core of Robotdalen’s focus on new technical solutions within the field of health robotics, says Erik Lundqvist, General Manager at Robotdalen. For further information, please contact Erik Lundqvist, General Manager at Robotdalen, email erik.lundqvist@robotdalen.se or phone +46 (0)21 10 70 26 or Lars Asplund, CEO at Robyn Robotics, email  lars.asplund@robynrobotics.se or phone +46 (0)705 41 46 68.

The rebirth of a legend - Jensen returns with limited edition Jensen GT

Almost 80 years since the Jensen name appeared on cars, the famous marque returns with the opportunity to order the first officially sanctioned model in 13 years. Marking the rebirth of the brand, the formation of the Jensen Group is the start of the next chapter in the Jensen story, following the collapse of the car manufacturer in 2002. Spearheaded by industry stalwart Tim Hearley, the return allows enthusiasts to purchase an officially sanctioned car, the Jensen GT. As the man responsible for the return of Jensen, and the force behind defending the Jensen trademark for almost four years, Tim Hearley, executive chairman of The Jensen Group, is delighted with the re-launch of the marque: “This represents the next chapter of Jensen and, as we look to the future, we want Jensen enthusiasts to help us celebrate as we unveil a completely new car and outline our plans for the future.” The Jensen Group is currently engaged on a project to launch Interceptor 2 in 2016, which may involve collaboration with an established automotive group. The Jensen GT will fill the gap between the last true Jensen, the Interceptor of 1976, and an all-new, state-of-the-art car due to be revealed in 2016. This new model, classed as Interceptor 2, will take design cues from the classic Interceptor and will advance the concept of the original grand tourer, to provide a thoroughly modern and exciting vehicle. Despite several companies claiming to be the spiritual home of Jensen, the Jensen GT is the first new car to legitimately bear a Jensen badge in the more than 13 years, since the demise of the S-V8 in 2001. This extremely limited edition will be built under an agreement between the Jensen Group and Jensen International Automotive (JIA), well known for their modified Interceptor R models. The Jensen GT will be available exclusively through JIA. ENDS Contacts For Jensen Group press information, please contact Torque: Matt Sanger       – 020 7952 1079 or msanger@torqueagencygroup.com Adam Forshaw – 020 7952 1082 or aforshaw@torqueagencygroup.com (aforshaw@torqueagencygroup.com%20) About The Jensen Group The Jensen Group licences, markets and uses the Jensen and Interceptor names for use within the automotive sector as well as other industries. The Jensen Group is currently engaged in a project to launch the new Interceptor 2 during 2016, which may involve collaboration with an established automotive group. www.jensengroup.co.uk

News release from Beijer Ref

The Swedish refrigeration wholesale group, Beijer Ref AB, is acquiring all the shares in the refrigeration wholesale company, RNA Engineering & Trading, which has its head office located in Kuala Lumpur, Malaysia. RNA Engineering & Trading was established in 1975. The company reports sales of approximately SEK 45M. RNA is the leading refrigeration wholesaler in Malaysia and includes Danfoss, Emerson and Thermal-Matic among its important brands. The Malaysian market for commercial refrigeration is estimated to be worth nearly SEK 480M, with stable growth in past years of around 10 per cent per annum. ”The acquisition complements our existing operation in the region and strengthens our presence outside Europe. This is fully in line with our strategy”, says Per Bertland, CEO of Beijer Ref. RNA Engineering & Trading is being acquired by Beijer Ref’s joint-venture company B Grimm in Thailand. The company will be integrated into Beijer Ref’s organisation and included in the company’s accounts from March 2015. The acquisition is expected to have a marginally positive effect of Beijer Ref’s net income in 2015. RNA Engineering & Trading’s management will continue to take an active part in the company. Malmö, 25 February 2015 Beijer Ref AB (publ) For further information, please contact: Per Bertland, CEO Telephone +46 40-35 89 00 Mobile +46 705-98 13 73 or Jonas Lindqvist, CFO Telephone +46 40-35 89 00 Mobile +46 705-90 89 04 BEIJER REF AB is a technology-oriented trading Group which, through added-value products, offers its customers competitive solutions within refrigeration and climate control. Beijer Ref is one of the largest refrigeration wholesalers in the world, and is represented in Belgium, Denmark, Estonia, Finland, France, Ireland, Italy, Latvia, Lithuania, Poland, Holland, Norway, Romania, Switzerland, Slovakia, Spain, United Kingdom, Sweden, the Czech Republic, Germany, Hungary, South Africa, Mozambique, Zambia, Botswana, Namibia, Malaysia and Thailand. www.beijerref.com

Nordic Nanovector ASA - Approved Listing Application

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT Oslo, 25 February 2015: Reference is made to the stock exchange notice 29 January 2015, announcing that Nordic Nanovector ASA (“Nordic Nanovector” or the “Company”) has submitted an application for listing of its shares on the Oslo Stock Exchange. In a meeting held today, the board of directors of the Oslo Stock Exchange approved the Company’s listing application and resolved to admit the shares of the Company to listing on the Oslo Stock Exchange, subject to the Company publishing an approved prospectus prior to the first day of listing. The board of directors of Oslo Stock Exchange authorised the chief executive officer of Oslo Stock Exchange to fix the date of the first day of listing, which is to be no later than 10 April 2015. The first day of listing on the Oslo Stock Exchange is expected to be end of March 2015. ABG Sundal Collier and DNB Markets (a part of DNB Bank ASA) are acting as Joint Global Coordinators and ABG Sundal Collier, Carnegie and DNB Markets are acting as Joint Bookrunners in the contemplated IPO.Information:Luigi Costa, CEOCell:    (41) 79 124 8601  Fax:    (47) 22 58 00 07E-mail: lcosta@nordicnanovector.comTone Kvåle, CFOCell:    (47) 91 51 95 76Fax:    (47) 22 58 00 07E-mail: tkvale@nordicnanovector.comAbout Nordic NanovectorNordic Nanovector was established in 2009 and has its main office and laboratories in Oslo, Norway. The Company aspires to become a leading provider of Antibody-Radionuclide-Conjugate (“ARC”) clinical solutions, to address major unmet medical needs and to advance cancer care through its innovative therapy programs and patented technologies. The Company intends to directly commercialize its product candidates, by creating a differentiated and specific positioning, investing in cross-specialty collaboration and medical education. The Company is also committed to continue developing the ARC pipeline leveraging on its proprietary nanovector targeting technology.The Company’s lead product candidate, Betalutin™, is an Antibody-Radionuclide-Conjugate that aims to prolong the survival and improve the quality of life of patients who suffer from non-Hodgkin Lymphoma (“NHL”), a life-threatening blood cancer with a high unmet medical need. The product candidate is currently undergoing a Phase I/II clinical trial for treatment of relapsed NHL.Further information about the Company can be found at www.nordicnanovector.com. IMPORTANT INFORMATIONUnited StatesThese materials may not be published, distributed or transmitted in the United States, Canada, Australia or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the “Shares”) of Nordic Nanovector ASA (the “Company”) in the United States, Norway or any other jurisdiction. The Shares of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”). The Shares of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to “qualified institutional buyers” as defined in Rule 144A under the U.S. Securities Act. European Economic AreaAny offering of securities will be made by means of a prospectus to be published that may be obtained from the issuer or selling security holder, once published, and that will contain detailed information about the Company and its management, as well as financial statements. These materials are an advertisement and not a prospectus for the purposes of Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not subscribe for any securities referred to in these materials except on the basis of information contained in the prospectus. In any EEA Member State other than Norway (from the time the prospectus has been approved by the Financial Supervisory Authority of Norway, in its capacity as the competent authority in Norway, and published in accordance with the Prospectus Directive as implemented in Norway) that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at “qualified investors” in that Member State within the meaning of Article 2(1)(e) of the Prospectus Directive (“Qualified Investors”), i.e., only to investors to whom an offer of securities may be made without the requirement for the Company to publish a prospectus pursuant to Article 3 of the Prospectus Directive in such EEA Member State. United KingdomIn the United Kingdom, these materials are only being distributed to and are only directed at Qualified Investors who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “Order”) or (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.) (all such persons together being referred to as “Relevant Persons”). These materials are directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. 

New Wave Group employs Joakim Sylmé

New Wave Group has recruited Joakim Sylmé as responsible for the Group's purchasing and trading within the product areas gifts and hard promotional articles with location in Shanghai, China. Joakim Sylmé, with over 25 years experience within corporate promo, has been active in both the dealer and wholesale segments. Over the past 13 years, his focus has been on international business development and Supply Chain Management in the Dutch wholesale company Xindao Shanghai Ltd. (Shanghai / China), where he, since 2006, also been the CEO. Joakim's responsibilities have been within the product areas for gifts and hard promotional articles. "I feel incredibly inspired to be back in the New Wave Group and as a step to further develop the group, I enthusiastically looking forward to adding my skills from China and share my experiences into new product areas. New Wave Group has a unique position in the market and a lot of confidence in their dealers. We will manage this confidence well by strengthening and expanding the range and increasing opportunities to do business together", says Joakim Sylmé. "I am very proud and happy that Joakim join us and he will mean a lot for our future development within the gifts and hard promotional articles" says Torsten Jansson, CEO. New Wave Group AB is listed on NASDAQ OMX Nordic Exchange in Stockholm. New Wave Group is a growth company that designs, acquires and develops brands and products in the corporate promo, sport, gifts and home furnishings sectors. For more information, please visit www.nwg.se. Göteborg, February 25, 2015 New Wave Group AB (publ) Torsten JanssonCEO & PresidentTel: +46 31 712 89 01

Planmed Verity® Extremity CT Scanner Added to Novation Contract with Merry-X-Ray

The Planmed Verity® extremity scanner is designed to find even the most subtle extremity fractures during the patient’s first visit to a clinic – the types of fractures that are often missed when using only 2D radiographs. The Planmed Verity extremity scanner provides fast pre- and postoperative 3D imaging at the point of care – enabling high resolution images with lower patient dose than full-body CTs. Unlike any other 3D imaging device, Planmed Verity also allows for weight-bearing imaging of the extremities. The mobile scanner adapts to different patient needs with anatomy-specific imaging programs, movements, and trays. Easily adjustable soft-surfaced gantry and motorized positioning trays support comfortable positions for various examination procedures. The adjustable user interface and efficient all-in-one workflow are also designed to maximize the operator’s soothing presence for the patient. The Planmed Verity CT scanner was also awarded Novation’s Innovative Technology designation following a review by Novation’s Imaging Council, which indicated the Planmed Verity CT scanner offered incremental benefit over other products available on the market. Olya Carter, RN and Senior Clinical Manager at Novation, said, “We are pleased that Novation-served hospital representatives recognized the unique benefits of the Planmed Verity CT system and awarded it the company’s Innovative Technology designation.” For further information, please contact:Mr Vesa Mattila, Managing Director, Planmed Oy                                                                                      Tel. +358 20 7795 301                                                                                                       vesa.mattila@planmed.com Planmed Oy and the Planmeca Group Planmed Oy develops, manufactures, and markets high technology imaging devices for mammography and orthopedic imaging. Planmed’s products are sold in more than 70 countries worldwide, with considerable market shares in Europe, Japan, and Oceania, as well as in North and Latin America. The company is headquartered in Helsinki, Finland.Planmed Oy is a part of Planmeca Group, which operates in the field of health care technology. The Group’s turnover is MEUR 740 (2014) with nearly 2,700 employees worldwide.www.planmed.com Merry X-Ray Corporation Merry X-Ray Corporation distributes X-ray equipment, accessories, and supplies throughout the United States. Merry X-Ray’s Service Department performs service, maintenance, and installation of conventional and digital x-ray equipment. Founded in 1958, Merry X-Ray Corporation has a reputation as the "Go To" distributor for all X-ray imaging needs. The company provides service to all 48 contiguous states, as well as Hawaii and Alaska, making it the largest distributor of X-ray equipment nationwide. Merry X-Ray Corporation represents and supports over 10,000 products. The company employs approximately 500 team members. www.merryxray.com

Saab Selects AEL Sistemas as a New Gripen Supplier in Brazil

The new avionics systems programme will run over four years and includes development, integration and production work to be performed in Porto Alegre. System integration work will be undertaken by Saab and Embraer.The WAD for Brazil’s Gripen NG aircraft is a single intelligent and full-redundant multi-purpose display system, full-colour, large-screen (19 x 8 in) with continuous image presentation and the state-of-the-art touch-screen controls capability. It is the primary source of all flight and mission information in the cockpit.AEL will also develop a new HUD for Brazil’s Gripen NG aircraft. The HUD provides essential flight and mission information to the pilot when looking ‘heads up’ out of the cockpit.“Incorporating these advanced products from AEL into Brazil’s Gripen NG further enhances the aircraft. This agreement also shows our continuing commitment to develop and produce the Gripen in close partnership with Brazilian industry,” says Ulf Nilsson, head of Saab business area Aeronautics.“We are proud of the opportunity to take part in the development process of Gripen NG and to be able to introduce the latest displays, computer and software technologies into a next generation fighter. I am sure it will further enhance the successful contribution of AEL to the Brazilian Military Forces,” says Sérgio Horta, President AEL.An extensive flight test campaign will be conducted in close co-operation with AEL at Saab’s site in Linköping, Sweden, to demonstrate and validate the new equipment.The transfer of technology contract with AEL will focus on further development of the human machine interface (HMI) for advanced fighters, along with workshops for avionics maintenance. Activity under this contract will commence in the second half of 2015 at Saab in Linköping and will include theoretical courses and on-the-job-training.For further information, please contact:Saab Press Centre, +46 (0)734 180 018,presscentre@saabgroup.comwww.saabgroup.comwww.saabgroup.com/YouTubeFollow us on twitter: @saabSaab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

CTT SYSTEMS receives first airline order for A350-900 humidifiers

The airline has ordered humidifiers for flight deck and flight crew rest compartment to be installed in its first A350-900 aircraft. The airline has in total 12 A350-900 on order and is operating a fleet of Boeing 787s equipped with CTTs flight deck/crew rest humidifiers. The flight deck air is normally extremely dry as is the air in the crew rest compartments. By humidifying the air, work and rest conditions improve significantly. Not only will crew benefit from higher humidity levels during flights, but they will also recover faster during layovers and return flights. “CTT is pleased with this first A350-order and delighted that it is from a Boeing 787-customer reassuring our product humidifiers are sought after for the world’s two most advanced commercial aircraft,” says Peter Landquist, Vice President Sales & Marketing of CTT Systems. “The airline demand for flight deck/crew rest humidification is clearly defined and proven on the Boeing 787 aircraft. With this recent order, we are honoured to be the sole supplier for both the Airbus A380 and A350XWB”. About CTT SYSTEMS CTT’s Zonal Drying™ System is basic equipment on all Boeing 787 “Dreamliner” aircraft and the humidifiers are standard in all crew rest compartment fitted Dreamliner aircraft and optional for flight deck. The flight deck humidifier is optional on the A350XWB aircraft, the crew rest compartments humidifiers are optional on both A380/A350XWB and the Zonal Drying™ and Cair™ systems are optional on the A350XWB aircraft. Cair™ is the leading cabin humidification system maintaining the relative humidity above 20% without causing condensation. The cabin air in First Class is normally extremely dry (3-5%). Cair increases passengers wellbeing by reducing dry air related problems (e.g. fatigue, jet-lag, red eyes, dry skin, spread of virus diseases). The dual-purpose system increases humidity for greater comfort and the anti-condensation Zonal Drying™ System prevents condensation from actively humidifying the cabin air. Also visit: www.ctt.se For additional information: Torbjörn Johansson, President, CTT Systems AB.Tel. +46-155-205901 alt. mobile. +46-70-665 24 46, or E-mail: torbjorn.johansson@ctt.se Peter Landquist, VP Sales, Marketing & Customer Support CTT Systems AB.Tel. +46-155-205902 alt. mobile. +46-70-665 24 45, or E-mail peter.landquist@ctt.se                      This information is disclosed by CTT Systems AB in accordance with the Swedish Securities Markets Act, the Swedish Financial Instruments Trading Act, or the requirements stated in the listing agreements. The information was submitted for publication on February 25, 2015 at 13:45 (CET)

1 in 3 people over 55 not making educated financial decisions

The survey highlighted people’s misconceptions about certain products with: · 23.8% not understanding what an over 50s life insurance plan provides. · 11% of respondents wrongly believing that an over 50s life insurance policy guarantees to pay your funeral costs. · 32% unaware of the difference between a funeral plan and over 50s life insurance Commenting on the study, Ashley Shepherd, Managing Director at Over50choices.co.uk, the leading over 50s comparison site, said “People need to be better informed about their funeral planning options, as they could be buying a product that isn’t the most appropriate for their needs - and therefore perhaps not protecting their family in the way they had wished. “Both plans have an important role to play but worryingly nearly a third of people don’t know what this is. Whilst a funeral plan will guarantee your funeral director’s costs, an over 50s life insurance plan will only give you a cash sum to help with funeral costs; a pot of money that will be eroded by inflation over the years. “It’s easy for the consumer to be confused, particularly online where both types of plans are promoted under various ‘funeral plan’ terms. What is concerning is that families could be left with heartache and a financial burden that they could be paying for in years to come”. Ashley explains that: · the average cost of a funeral today is £3,590**, · in 20 years time with funeral inflation this could rise to over £11,000***. He cites an example of a 60 year old man who purchases over 50s life insurance with a cash sum of £5,000 today. Based on the figures above, if he dies aged 80, his family could be left with a £6,000 shortfall when arranging his funeral. Ashley summarises: “The final decision for some could be down to budget. With an over 50s life insurance plan typically starting from £8 a month, they are considerably cheaper than funeral plans. Though when the time comes to make a claim on the policy, it may not be fit for purpose if the customer thought all their funeral costs would be covered. “Whilst better consumer education is needed, the life insurance companies need to do their bit to make sure it’s crystal clear that a policy will meet a customer’s expectations.” Ends *Google Survey carried out on behalf of Over50choices.co.uk, February 2015 ** SunLifeDirect report (https://www.sunlifedirect.co.uk/WorkArea/DownloadAsset.aspx?id=19327353063) ***Over50choices funeral calculator (http://www.over50choices.co.uk/funeral-planning/paying-for-a-funeral/funeral-calculator)

PA Resources receives approval for deferred interest payments

The bondholders in PA Resources’ NOK and SEK denominated bonds, have at the bondholders meeting and by the written procedure respectively, approved PA Resources’ proposal announced on 10 February 2015 of, inter alia, deferred interest payments. The decision to approve the proposal obtained 99.86% of the votes in the written procedure for the SEK bonds and was unanimous in the bondholders meeting for the NOK bond. In summary, the approval means that the originally scheduled payment dates in October 2014 under the bonds have been deferred to 31 March 2015 and that, consequently, interest payments owed to PA Resources’ largest creditor and shareholder, the Gunvor Group, under credit facilities with them, are deferred until 31 March 2015. Notwithstanding the interest payment deferrals, a majority of the bondholders, and the Gunvor Group, are entitled under the respective agreements to give notice to bring the relevant interest payment dates forward to the third business day following the date on which the notice is given. Stockholm, 26 February 2015 PA Resources AB (publ) For queries, please contact: Tomas HedströmCFOPA Resources ABTel: +46 (0)8 545 211 50E-mail: ir@paresources.se PA Resources AB (publ) is an international oil and gas group which conducts exploration, development and production of oil and gas assets. The Group operates in Tunisia, Republic of Congo (Brazzaville), Equatorial Guinea, United Kingdom, Denmark, Netherlands and Germany. PA Resources is producing oil in West Africa and North Africa. The parent company is located in Stockholm, Sweden. PA Resources’ net sales amounted to SEK 1,049 million in 2013. The share is listed on the NASDAQ OMX in Stockholm, Sweden. For additional information, please visit www.paresources.se. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07.45 a.m. CET on 26 February 2015.

Bariatric surgery affects risk of pregnancy complications

Pregnant women with obesity run a higher risk of developing complications during pregnancy and risks of fetal/infant complications are also higher. There has been a sharp rise in the number of women becoming pregnant after bariatric surgery; in 2013 almost 8,000 such operations were performed in Sweden, 80 per cent of which were on women. “The effects of bariatric surgery on health outcomes such as diabetes and cardiovascular disease have been studied, but less is known about the effects on pregnancy and perinatal outcomes,” says the study’s lead author, Kari Johansson, PhD, from the Department of Medicine in Solna. “Therefore we wanted to investigate if the surgery influenced in any way the risk of gestational diabetes, preterm birth, stillbirth, if the baby was small or large for its gestational age, congenital malformations and neonatal death.” Using data from nationwide Swedish health registries, the researchers identified 596 pregnancies to women who had given birth after bariatric surgery between 2006 and 2011. These pregnancies were then compared with 2,356 pregnancies to women who had not been operated upon but who had the same body mass index (BMI, weight divided by height squared) as the first group prior to surgery. What researchers found was that the women who had undergone surgery were much less likely to develop gestational diabetes – 2% compared to 7% – and give birth to large babies. Just over 22% of women in the comparison group had babies that were large for gestational age, and barely 9% of the operated women. On the other hand, the operated women were twice as likely to give birth to babies who were small for gestational age, and the pregnancies were also of shorter duration. “Since bariatric surgery followed by pregnancy has both positive and negative effects, these women, when expecting, should be regarded as risk pregnancies,” says Dr Johansson. “They ought to be given special care from the maternal health services, such as extra ultrasound scans to monitor fetal growth, detailed dietary advice that includes checking the intake of the necessary post-surgery supplements.” The study was financed by the Swedish Research Council, The Obesity Society, Karolinska Institutet and the Stockholm County Council.     Publication: “Outcomes of Pregnancy in Women with Prior Bariatric Surgery (http://www.nejm.org/doi/full/10.1056/NEJMoa1405789)”, Kari Johansson, Sven Cnattingius, Ingmar Näslund, Nathalie Roos, Ylva Trolle-Lagerros, Fredrik Granath, Olof Stephansson, & Martin Neovius, New England Journal of Medicine (http://www.nejm.org/) online 26th February 2015.

Clavister Secures Mexican Universities Wi-Fi networks

Clavister provide a purpose built solution comprising its next generation X8 and W3 firewalls and its cOS core security software to deliver a secure, reliable Wi-Fi network with extensive coverage and supporting traffic management and tracking. The solution handles multiple access points and a high volume of concurrent users, providing robust security to the entire coverage area and enforces the Universities functionalities such as web filtering and tracking policies together with applications’ bandwidth management. The reliability of the solution with minimum downtime was essential in the decision process which Clavister solution fulfilled. Main features of the deployment include firewall, VPN, application control, policy and bandwidth enforcement, DHCP, web filtering and prevention of application-based vulnerabilities. Jim Carlsson, CEO of Clavister, said: “Working with Ericsson Mexico and Telmex we have delivered a large and secure, high-performance reliable and scalable Wi-Fi network to both the Universities and their students. Our solution enabled the University to ensure that students can securely access its network from a wide variety of locations, delivering an enhanced student experience, and maximising availability of resources.  The management level of the network will enable them to overcome the challenges of managing data in a variety of public locations while also enforcing its network policies to users.” In addition to the secure Wi-Fi network the Universities also wanted to be able to monitor network usage, including websites accessed, traffic generated and capabilities to prioritise bandwidth linked to applications to guarantee, prioritize and limit bandwidth based on applications related to authentication credentials.  The Clavister solution was selected following testing on a number of solutions in which Clavister impressed with its scalability and levels of traffic it could manage. Unlike other solutions Clavister’s could support thousands of users logging in simultaneously and demonstrating the capacity for extremely high volumes of network activity. In addition to being able to identify and track all users on the network via its external built in DHCP server the functionality delivered constant uptime during peak hours. In 2015 Clavister has also started work on a number of projects to deliver secure Wi-Fi networks including the Brazil “Smart Cities” initiative, with a focus on securing wireless networks at up to 1600 locations in the country and with the Swedish Hockey League to provide a secure platform to offer fans value-added in stadium services. 

PA Resources’ Year-end Report 2014

FULL YEAR · Group revenue totalled SEK 603 million (1,049) · EBITDA was SEK -480 million (-494) · Profit after tax was SEK -2,957 million (-1,219) · Earnings per share were SEK -26.13 (-21.54) · The Board of Directors proposes to the Annual General Meeting that no dividend be paid for the 2014 financial year. FOURTH QUARTER · Group revenue totalled SEK 88 million (193) · EBITDA was SEK -808 million (74) · Profit after tax was SEK -2,745 million (-402) · Earnings per share were SEK -24.26 (-3.55) +-----------------------------+|KEY EVENTS DURING THE QUARTER|+-----------------------------+ · Impairment charges resulted in a net effect of SEK -1,820 million recorded in profit for the period. The corresponding amount in equity was SEK -2,073 million. · Agreement to divest PA Resources’ 30 percent interest in Netherlands offshore Blocks Q7 and Q10a to Tulip Oil. · PA Resources awarded 25 percent of Blocks 22/18c and 22/19d in UK 28th Round containing the large Ekland prospect. · The farm out agreement for the transfer of 70 percent interest in each of the Didon field and the Zarat Permit to EnQuest has been terminated. PA Resources accounts for the termination as a one-off item in the fourth quarter, with a total net profit impact of SEK -826 million. SUBSEQUENT EVENTS · Lenders agreed to defer the interest payments due in February 2015 to 31 March 2015. · Successful Lille John appraisal well and sidetrack. · PA Resources awarded 33 percent in Block 21/24b in UK 28th Round containing the West Teal discovery. · PA Resources postponed release of the annual report until 29 April 2015 and the AGM as well as publication of the Q1 report until 29 May 2015. · PA Resources AB’s board of directors has resolved to convene an extraordinary general meeting of shareholders to be held Friday 27 February 2015 to determine whether or not the company should go into liquidation FINANCIAL KEY RATIOS Oct-Dec Jan-Dec 2014 2013 2014 2013Average production, barrels/day 2,900 3,600 3,100 5,000Revenue, SEK million 88 193 603 1,049EBITDA, SEK million -808 74 -480 -494EBITDA margin, % -914% 38% -80% -47%Operating profit, SEK million -2,856 -296 -2,667 -1,234Profit for the period, SEK million -2,745 -402 -2,957 -1,219Earnings per share after dilution, SEK -24.26 -3.55 -26.13 -21.54 For the complete report, see attached file. Stockholm, 26 February 2015PA Resources AB (publ) For queries, please contact:Tomas Hedström, CFO+46 8 545 211 50 Mark McAllister, President and CEO+46 8 545 211 50 ir@paresources.se Webcast conference call PA Resources' results for the fourth quarter of 2014 will be presented on 26 February 2015 at 09 a.m. (CET) via a webcast conference call. To participate, use the following link: Link to webcast: http://edge.media-server.com/m/p/g3ky9ait To participate via phone, please call:Sweden: + 46 8 505 564 74UK: +44 203 364 5374US: +1 855 753 2230 PA Resources AB (publ) is an international oil and gas group which conducts exploration, development and production of oil and gas assets. The Group operates in Tunisia, Republic of Congo (Brazzaville), Equatorial Guinea, United Kingdom, Denmark, Netherlands and Germany. PA Resources is producing oil in West Africa and North Africa. The parent company is located in Stockholm, Sweden. PA Resources’ net sales amounted to SEK 1,049 million in 2013. The share is listed on the NASDAQ OMX in Stockholm, Sweden. For additional information, please visit www.paresources.se. The above information has been made public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 08:00 am CET on 26 February 2015.

Interim financial report for the 12 month period ending December 31, 2014,   and for the quarter October – December 2014

Highlights during the quarter October – December 2014 · Nickel Mountain Group AB (“NMG”) held an Extraordinary General Meeting (“EGM”) on October 10, 2014 during which a new Board of Directors was appointed and a fully underwritten rights issue was approved. · The rights issue amounted to about 68 million NOK, and the terms of the issue were 3 new shares for 1 existing share on the record day. The issue price was 1 NOK per share. The rights issue was fully underwritten and was fully subscribed to in November 2014. · During the autumn of 2014, the first statements of defence were received from the defendants in the civil court case initiated by NMG against its former board members. A ruling by the Stockholm District Court is expected no earlier than year-end 2015, if not into 2016. · The financial position and liquidity situation of the group, following the recently completed rights issue, can now be considered satisfactory for the first time in two years. · In October 2014, the Supreme Administrative Court issued a positive ruling, from NMG’s point of view, in terms of the granted exploitation concessions for the Rönnbäcken Nickel Project (“RNP”). · Another EGM of NMG was convened on December 17, 2014 whereby PricewaterhouseCoopers (“PwC”) were elected as the new auditor of the Parent Company and of the Group. Financial results for the 12-month period 2014 and for the quarter October – December 2014 · The net result after tax for the 12-month period January – December 2014 amounted to MSEK –16.0 (MSEK –110.2). This corresponds to earnings per share (EPS) of SEK –0.54 (SEK –6.06). · The sale of former subsidiary IGE Diamond in June 2014 has positively affected the net result for the report period by approximately MSEK +2. · The total comprehensive loss for the full 12-month period of 2014 was MSEK –17.1 (MSEK –117.0). · The net result after tax for the October – December quarter of 2014 amounted to MSEK –4.2 (MSEK –20.1). This corresponds to earnings per share (EPS) of SEK –0.08 (SEK –1.11). · The total comprehensive loss for the quarter October - December 2014 was MSEK –5.3 (MSEK –20.8).

Alfa Laval wins SEK 55 million power order in the Middle East

The Alfa Laval compact heat exchangers will be used for cooling duties in an IGCC power plant. IGCC is a technology where coal and other carbon-based fuels are turned into synthesis gas, which is subsequently used to produce steam for power generation. “We are happy to announce yet another large energy-related order and this time from the demanding power industry,” says Lars Renström, President and CEO of the Alfa Laval Group. Did you know that… once completed, this will be one of the largest gasifier-based power facilities in the world? About Alfa Laval                                                                                                         Alfa Laval is a leading global provider of specialized products and engineering solutions based on its key technologies of heat transfer, separation and fluid handling. The company’s equipment, systems and services are dedicated to assisting customers in optimizing the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol. Alfa Laval’s products are also used in power plants, aboard ships, oil and gas exploration, in the mechanical engineering industry, in the mining industry and for wastewater treatment, as well as for comfort climate and refrigeration applications. Alfa Laval’s worldwide organization works closely with customers in nearly 100 countries to help them stay ahead in the global arena. Alfa Laval is listed on Nasdaq OMX, and, in 2014, posted annual sales of about SEK 35.1 billion (approx. 3.85 billion Euros). The company has about 18 000 employees. www.alfalaval.com For more information please contact:Peter TorstenssonSenior Vice President, CommunicationsAlfa LavalTel: + 46 46 36 72 31Mobile: +46 709 33 72 31Gabriella GrotteInvestor Relations ManagerAlfa LavalTel: +46 46 36 74 82Mobile: +46 709 78 74 82

Year-end report, 2014 Rabbalshede Kraft AB (publ)

2014 fiscal year · Production from the Group’s wind farms during January-December amounted to 314,665 MWh (189,431).   · Net sales totaled KSEK 146,161 (104,694). · EBITDA amounted to KSEK 81,270 (77,821). · EBIT was KSEK 14,325 (38,027). · The average sales price for wind power production amounted to SEK 497/MWh (560), of which electricity was SEK 315/MWh (351), electricity certificates and guarantees of origin were SEK 182/MWh (211). · Depreciation/amortization totaled KSEK 66,945 (39,794). Impairment losses on projects totaled KSEK 12,317. Impairment losses were incurred on the Årjäng NO and Ljungskile Hoven projects that had not received permits, and by other projects that were discontinued or pending due to unfavorable conditions. · The Company posted a loss after tax of KSEK 25,083 (profit: 117). · All 33 wind turbines in the Skaveröd/Gurseröd, Årjäng NV and Årjäng SV wind farms are in production. The wind farms were put into commercial operation from December 2014. The wind farms are expected to produce 289,400 MWh/year, which will increase Rabbalshede Kraft’s production capacity by 130 percent. · Rabbalshede Kraft was granted an environmental permit for the Årjäng NV II wind farm comprising up to eight wind turbines (28 MW). The wind farm gained legal effect in July 2014. · Rabbalshede Kraft was granted an environmental permit for the Lyrestad wind farm comprising up to eight wind turbines (25 MW). The wind farm gained legal effect in January 2014. · The Board of Rabbalshede Kraft decided to start trading in the Company’s share on the Alternativa equities market on the Alternativa Lista. · The Annual General Meeting for the 2013 fiscal year was held on April 25, 2014, in Gothenburg, Sweden. · The Company employed Lars Jacobsson as its new Operational and Maintenance Manager. Lars assumed his position in April 2014 and is now part of the Company’s management.

St David’s Day launch of Welsh Slate Aged Cavern Cheddar in Welsh stores

The new Cheddar, packed in the Creameries’ Dragon brand, has been developed in partnership with Llechwedd Slates Caverns. The cheese adopts a very traditional maturing method transported from the creameries’ Chwilog base to the Slate Cavern in Blaenau Ffestiniog and left to mature 500 feet underground. This maturation process, believed to be in the steepest mining maturation caverns, adds unique characteristics to the cheese; a firmer body and depth of flavour with rich savoury notes. To celebrate the launch of this authentic Welsh cheese and to coincide with St David’s Day, a cheese tasting weekend has been arranged at Llechwedd Slate Caverns on 28thFebruary and 1stMarch. The cheese is presented in a 200g pack under South Caernarfon Creameries’ own Dragon brand and is available to buy at local Welsh retailers.  Alan Wyn-Jones, Managing Director at South Caernarfon Creameries said “We have deliberately launched our Dragon Welsh Slate Aged Cavern Cheddar to coincide with St David’s Day. The process used in that the cheese is made from Welsh milk produced by our member farmers and left to mature deep in the mine at Blaenau Ffestiniog really highlights our Welsh heritage. St David’s Day seemed the perfect time to launch into Welsh stores and we hope that local people enjoy the Slate Aged Cavern Cheddar as it really has a distinct, mature flavour and a fabulous eating quality.” Ends

Cortendo to Present at Upcoming Investor Conferences

February 26, 2015 – Göteborg, Sweden and Radnor, Penn., USA – Cortendo AB (http://www.cortendo.com) [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today announced President and CEO Matthew Pauls will present corporate updates at three investor conferences in March:  Cowen and Company 35th Annual Health Care Conference (http://www.cowen.com/conferences/upcoming-conferences/)Presentation: March 2, 2015 at 3:30 p.m. EST in the St. Botolph roomLocation: The Boston Marriott Copley Place, Boston, Mass. 27th Annual ROTH Conference (http://www.roth.com/main/page.aspx?pageid=7207)Presentation: March 10, 2015 at 8:30 a.m. PST in Salon 2Location: The Ritz Carlton, Dana Point, CA 22nd Annual Future Leaders in the Biotech Industry Conference (http://www.biocentury.com/conferences/futureleaders/dates)Presentation: March 20, 2015 at 9:00 a.m. EST in Room 508Location: Millennium Broadway Hotel and Conference Center, New York City, NY About Cortendo ABCortendo AB is a global biopharmaceutical company incorporated in Sweden and based in the United States. The Company’s strategic focus is to be the global leader in commercializing innovative medicines for orphan endocrine disorders. Cortendo is leading the way in the field of cortisol inhibition through the investigational drug, COR-003 (levoketoconazole), currently being studied in the global Phase 3 SONICS trial for the treatment of Cushing’s syndrome. COR-003 (levoketoconazole) has received orphan designation from both the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The Company’s intent is to independently commercialize its Orphan/Endocrine assets in key global markets and partner non-strategic product opportunities, such as diabetes, at relevant development stages. Risk and UncertaintyThe development of pharmaceuticals carries significant risk. Failure may occur at any stage during development and commercialization due to safety or clinical efficacy issues. Delays may occur due to requirements from regulatory authorities, difficulties in recruiting patients into clinical trials due to physician or patient preferences or competing products, not anticipated by the Company. There is no assurance that Cortendo will receive marketing and regulatory approvals necessary to commercialize or produce COR-003 (levoketoconazole) or other products. Regulatory approvals may be denied, delayed, limited or revoked. The commercial success of COR-003 (levoketoconazole), if approved in a territory, cannot be predicted with certainty. In addition, Cortendo may face the risk of interrupted supply of COR-003 for clinical or commercial use from the subcontractors Cortendo has contracted. Cortendo Forward-Looking StatementsThis press release contains forward-looking statements concerning Cortendo that involve a number of risks and uncertainties. All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, plans, projects to enhance efficiency, outcomes of products development, future capital expenditures, liquidity requirements and objectives of management for future operations, may be deemed to be forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements or industry results to be materially different from those contemplated, projected, forecasted, estimated or budgeted, whether expressed or implied, by these forward-looking statements. Given these risks and uncertainties, investors should not place any undue reliance on forward-looking statements as a prediction of actual results. None of these forward-looking statements constitutes a guarantee of the future occurrence of such facts and data or of actual results.  These statements are based on data, assumptions and estimates that the Company believes are reasonable. The forward-looking statements contained in this document are made only as of the date hereof. The Company expressly disclaims any obligation or undertaking to release publicly any updates of any forward-looking statements contained in this press release to reflect any change in its actual results, assumptions, expectations or any change in events, factors, conditions or circumstances on which any forward-looking statement contained in this press release is based. ### Corporate:Alexander LindströmChief Financial Officer, Cortendo AB+1 610-254-9200alindstrom@cortendo.comInvestors and Media:LaVoieHealthScienceDonna LaVoie and David Connolly+1 617-374-8800dlavoie@lavoiehealthscience.comdconnolly@lavoiehealthscience.com Sweden:Box 47SE-433 21 PartilleTel. / Fax. +46 (0)31-263010USA:555 East Lancaster Ave.Suite 510Radnor, PA 19087Tel. +1 610-254-9200Fax. +1 610-254-8005

Trigon Agri A/S announces that the bondholders have approved the extension of the maturity of its SEK 350 million bond

Trigon Agri A/S (the ‘Company’) today held the bondholder meeting of its SEK 350 million bond issue, where the bondholders approved the extension of the maturity of its SEK 350 million bond until August 31, 2017 on the terms disclosed earlier in the release announcing the bondholder meeting. At the meeting and the written procedure, bondholders representing 51.64% of the outstanding nominal amount unanimously approved the proposed amendments. The amendments entered into force immediately and the amended and restated terms and conditions can be found on the following web-link: www.corpnordic.com. Trigon Agri Chairman of the Board Joakim Helenius comments: “We are pleased to have received the support of our bondholders in today’s vote. The Company is showing strong operational results and cash flow despite the challenging regional conditions and low soft commodity prices, and now that we are no longer under immediate pressure from the maturing bonds we will return to implementing our previously announced strategy ” For further information please contact: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com.If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

Why Natural Gas Prices are Headed Much Lower

     Coming into this winter you wouldn't have found a bigger bull, than myself, when it concerned natural gas prices. The frigid memories of last winter were still in my head, and we were entering this one with a large deficit in natural gas inventories. A funny thing happened--winter for a large part of the country west of the Mississippi, was never more than a few small instances of snow and ice. The same of course could not be said for the east coast with record snowfall and bitter cold for much of February. And that's the point; it was only February, the beginning of the winter for the northeast was almost pleasant. When you coupled the lack of sustained cold with the amazing production gains in natural gas it was a recipe for lower prices--and ones that could go much lower from here in my opinion. We just finished one of the coldest weeks on record and the draw in natural gas fell well short of expectations when the number was released earlier today. This is happening because of the production gains in fracking --just as in crude oil, the fracking revolution has permeated the natural gas markets. We are now almost 50% above supply figures than we were last year at this time. When you look at the calendar you realize there are about 4 weeks of winter left. This is one of the best scenarios someone looking to short Nat gas could ask for ; projected lower demand and higher production. For these reasons this bull has now become a bear--I am looking to sell the market-- the 50 day Moving average comes in around 293 and offers good resistance.  My belief is you could short Natural gas within 10 handles of this level. If temps moderate quickly this spring and production of Nat gas continues at its current pace--we could see a 230 to 220 handle in prices by April. We are entering what I call the in-between season where Nat gas is not used for heating or cooling--demand falls considerably.Anthony Grisanti --President GRZ Energy

TROAX ANNOUNCES ITS INTENTION TO PROCEED WITH AN INITIAL PUBLIC OFFERING AND LISTING ON NASDAQ STOCKHOLM

Hillerstorp 27 February 2015, 07.00 CET Nasdaq Stockholm has decided to admit Troax’ shares to trading, subject to customary conditions, such as a prospectus being approved by the Swedish Financial Supervisory Authority, the distribution requirements in respect of the Company’s shares being fulfilled no later than on the first day of trading and approval from the board of the principal shareholder. Depending on market conditions, the listing is expected to be completed during the first half of 2015. The IPO will comprise existing shares primarily sold by the Company’s current principal owner FSN Capital LP III. The shares will be offered to qualified institutional investors in Sweden and internationally, as well as to the public in Sweden. The IPO will broaden the Company’s shareholder base and make it possible for Troax to use the Swedish and international capital markets to increase the Company’s financing options for future growth, both organically and through selective acquisitions. Carnegie Investment Bank is acting as Global Coordinator and Handelsbanken Capital Markets is acting as Joint Bookrunner. Troax highlights · Troax is the global market leader in metal-based mesh panel solutions in its three core business areas; Automation and Robotics, Material Handling and Logistics and Property Protection · Troax underlying market is characterized by structural growth from increased automation, safety and e-commerce trends · In its main addressable geographical market, Europe, the Company has a market share of around 20 percent. Troax global market share is 10 percent and Troax is almost two and a half times larger than its closest competitor · Troax is currently represented in 31 countries with 35 sales offices and 7 distribution hubs employing approximately 400 employees · 2014 pro forma sales and adjusted EBITDA amounted to EUR 91.2m and EUR 18.6m · In 2014, 54% of net sales was generated in Mainland Europe, 19% in the Nordics, 17% in the United Kingdom and 6% in New Markets +----------------------+-----+-----+-----------+|  |1 January – 31 December|+----------------------+-----+-----+-----------+|MEUR | IFRS| IFRS| Pro forma*|+----------------------+-----+-----+-----------+|  | 2013| 2014| 2014|+----------------------+-----+-----+-----------+|Net sales | 70.1| 84.5| 91.2|+----------------------+-----+-----+-----------+|Adj. EBITDA | 12.5| 17.2| 18.6|+----------------------+-----+-----+-----------+|Adj. EBITDA margin (%)|17.9%|20.4%| 20.5%|+----------------------+-----+-----+-----------+|Adj. EBITA | 10.7| 15.4| 16.7|+----------------------+-----+-----+-----------+|Adj. EBITA margin (%) |15.2%|18.2%| 18.4%|+----------------------+-----+-----+-----------+ * Pro forma includes full year financials 2014 for Troax and Satech (acquired in June 2014)  For additional information, please contact: Thomas Widstrand, CEOPhone: +46 370 828 31 Ola Österberg, CFOPhone: +46 370 828 25  IMPORTANT INFORMATION This announcement is not and does not form a part of any offer for sale of securities. Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures. The securities referred to in this announcement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and accordingly may not be offered or sold in the United States absent registration or an exemption from the registration requirements of the Securities Act and in accordance with applicable U.S. state securities laws. The Company does not intend to register any offering in the United States or to conduct a public offering of securities in the United States. Any offering of the securities referred to in this announcement will be made by means of a prospectus. This announcement is not a prospectus for the purposes of Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”). Investors should not invest in any securities referred to in this announcement except on the basis of information contained in the aforementioned prospectus. In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can receive the offer without an approved prospectus in such EEA Member State. This communication is only being distributed to and is only directed at persons in the United Kingdom that are (i) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”) or (ii) high net worth entities, and other persons to whom this announcement may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). This communication must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this communication relates is available only to relevant persons and will be engaged in only with relevant persons. Persons distributing this communication must satisfy themselves that it is lawful to do so. Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as “believe,” “expect,” “anticipate,” “intends,” “estimate,” “will,” “may,” "continue," “should” and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Troax believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this release by such forward-looking statements. The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

Change in number of shares and votes in Aerocrine etc.

With reference to Chapter 4 Section 9 in the Swedish Financial Instruments Trading Act, it is hereby announced that as a result of the recent rights issue in Aerocrine AB (Nasdaq Stockholm: AERO), the number of shares and votes in Aerocrine has increased during February 2015 as specified in the table below.  Number of shares and votesFebruary 1, 2015 155,416,387Increase 542,721,067February 27, 2015 698,137,454 It is further announced that Rolf Classon now has resumed his position as chairman of the Board of Directors, after being on sick leave since December 2014.  Solna February 27, 2015 Aerocrine AB (publ.) For further information, please contact: Marshall Woodworth, CFO, +1 919 749 8748 or +46 709 695 219 About Aerocrine Aerocrine AB is a medical products company focused on improved management and care of patients with inflammatory airway diseases such as Asthma. Within this sector, Aerocrine is the world leader. Aerocrine markets NIOX MINO® and NIOX VERO®, which enables fast and reliable point-of-care measurement of airway inflammation. These products plays a critical role in more effective diagnosis, treatment and follow-up of patients affected with inflammatory airway diseases. Aerocrine is based in Sweden with subsidiaries in the US, Germany, Switzerland and the UK. Aerocrine shares have been listed on the Stockholm Stock Exchange since 2007 (AERO-B.ST). For more information please visit www.aerocrine.com and www.niox.com. +-----------------------------------------------------------------------------+|Aerocrine is required to disclose the information provided herein pursuant to||the Securities Markets Act and/or the Financial Instruments Trading Act. The ||information was submitted for publication at 08:00 am on February 27, 2015. |+-----------------------------------------------------------------------------+

Trigon Agri A/S 4Q 2014 Interim Report

Highlights of 2014 Total revenue, other income, fair value adjustments and net changes in inventory amounted to EUR 74.5 million (EUR 75.4 million in 2013). EBITDA was a profit of EUR 13.6 million (loss of EUR 1.1 million in 2013). The Net loss was EUR 13.3 million (loss of EUR 16.8 million in 2013). Please note that the result includes EUR 12.3 million of non-cash currency translation losses due to the dramatic depreciation of the Rouble and Hryvna. The consolidated assets as of December 31, 2014 amounted to EUR 149.6 million (EUR 185.2 million at December 31, 2013). Trigon Agri’s Founder and Chairman of the Board, Joakim Helenius, Comments: Trigon Agri achieved an EBITDA of EUR 13.6 million in 2014 versus a negative EBITDA of EUR 1.1 million in 2013. This result was achieved despite the continued low soft commodity prices which in real terms for the second year running have remained near their historical all-time lows. In fact the actual prices achieved by Trigon Agri in 2014 were even lower than in 2013. Our continued focus on costs and operational efficiencies helped to achieve this result. Despite the good EBITDA result given the circumstances the net profit was severely impacted by non-cash currency translation losses driven by the dramatic drop in value of both the Ukrainian Hryvna and the Russian Rouble. Out of the reported net loss of EUR 13.3 million non-cash currency translation losses amounted to EUR 12.3 million. The dramatic currency depreciation has also significantly impacted the value of our assets measured in euros. The overall situation in the agricultural sectors of both Russia and Ukraine is strongly impacted by the political, economic and financial situation in the region. Trigon Agri itself has secured the working capital it needs for the 2015 season, however it would appear based on anecdotal evidence that a significant part of the agricultural producers are having serious trouble financing their working capital needs given the stressed state of the banking sectors in the two countries. This could mean that the regional harvest in 2015 will be negatively affected, possibly significantly so. Everything else being equal this should be positive for likely price developments in the region, assuming no export restrictions (such as the current Russian ones). As has been stated in a separate stock exchange release yesterday Trigon Agri bondholders voted unanimously to support an extension of the maturity of the bonds to August 2017. This gives us additional time to continue implementing our previously communicated divestment strategy, selling non-core assets in order to repay the bonds. Telephone conference details A telephone conference will be held today, on February 27, 2015 at 10.00 CET. Program: Joakim Helenius, Chairman of the Board, and Ülo Adamson, President and CEO, will present and comment upon the results. There will also be an opportunity to ask questions. To participate in the telephone conference, please call one of the following numbers: SE: +46 8 505 564 74 UK: +44 203 364 5374 US: +1 855 753 2230 FI: +358 981710460 NO: +47 235 002 10 DK: +45 354 45 580 CH: +41 225 675 541 The presentation material will be available on www.trigonagri.com before the telephone conference starts. A recording of the telephone conference will be available afterwards on www.trigonagri.com. Investor enquiries: Mr. Ülo Adamson, President and CEO of Trigon Agri A/S, Tel: +372 66 79200, E-mail: mail@trigonagri.com About Trigon Agri Trigon Agri is a leading integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri’s shares are traded on the main market of NASDAQ OMX Stockholm. Trigon Agri is managed under a management agreement by Trigon Capital, a leading Central and Eastern European operational management firm with around USD 1 billion of assets under management. For subscription to Company Announcements please contact us: mail@trigonagri.com. If you do not want to receive Trigon Agri press releases automatically in the future please send an e-mail to the following address: unsubscribe@trigonagri.com (mail@trigonagri.com).

Vattenfall wins concession for Horns Rev 3

Vattenfall Wind Power has won the concession to build and operate the offshore wind farm Horns Rev 3, with a total capacity of 400 MW. The wind farm will produce electricity for 450 000 households from 2017. Vattenfall’s CEO Magnus Hall welcomes the decision that Vattenfall had the most competitive bid. Now the company awaits approval from the Danish Parliament and EU. – The construction of Horns Rev 3 is an important step towards both Denmark’s and EU’s goals to reduce carbon dioxide emissions, goals that stipulate that 30 % of the total energy consumption in 2020 shall origin from renewable energy sources. For that reason, we trust the political majority to go along with the agreement and find a solution suitable for all parties, says Magnus Hall. – This large, planned offshore wind farm will affect Vattenfall’s ambitions concerning wind power and especially our focus on offshore wind farms. Today we are the second largest operator of offshore wind power farms in the world and one of the largest operators of on shore wind power in Denmark. That gives us even better ways and means to develop sustainable energy production to become both profitable and competitive – in benefit of the Danish consumers, says Magnus Hall. With Vattenfall as owner of the concession for Horns Rev 3, the company gets a unique opportunity for synergies between several offshore wind power farms, according to Alberto Mendez Rebollo, Head of Vattenfall Nordic Wind Power operations. – Our Control Center in Esbjerg today monitors more than 1000 wind turbines, offshore and on shore, and Horns Rev 3 will imply positive synergies in operation and maintenance of offshore wind farms in the Nordic Sea. Both the Control Center in Esbjerg and the community Esbjerg, will gain a more important role as a chain of support when Horns Rev 3 is in operation, says Alberto Mendez Rebollo. Offshore, Vattenfall owns 60 % of the wind farm Horns Rev 1, 80 wind turbines, and is currently building, together with Stadtwerke München, two offshore wind farms in the German part of the Nordic Sea: Dan Tysk and Sandbank. Besides that, Vattenfall is developing the wind farm Kentish Flats in the UK.In total, Vattenfall owns approximately 1800 MW, of which 1000 MW are offshore. For further information, please contact:Peter Stedt, Press Officer Vattenfall AB, +46 70 597 73 38 Vattenfall's Press Office,Phone: +46 (0) 8 739 50 10press@vattenfall.com Vattenfall is a Swedish owned energy company with operations in Sweden, Germany, the Netherlands, Denmark, UK, France and Finland. Vattenfall’s vision is to create a strong and diversified European energy portfolio and to be among the leaders in developing an environmentally sustainable energy systems.

myFC Debuts World’s Smallest Portable Fuel Cell Charger at Mobile World Congress

Barcelona, February 27th 2015 – Swedish innovation company myFC will premiere a new fuel cell charger, “JAQ,” at the Mobile World Congress. The new charger is a powerhouse –smaller, lighter, at a lower cost per charge, and a hefty improvement in capacity. The slimline card, which consists of ordinary water and salt and easily fits in a pocket or bag, represents a new way of charging. Users can easily charge mobile phones and tablets using the card, which lasts for one smartphone charge. No pre-charging in a power socket is needed as electricity is created instantly on the spot when the card is activated. The new charger debuts at the Mobile World Congress (booth 7F41, hall 7) and will be in stores in Q4 2015. “Mobile accessibility is critical for everyone and the demand for charging solutions for mobile phones, tablets, and cameras is increasing,” says Björn Westerholm, CEO of myFC AB. “The dramatic reduction of the size of both the fuel and charger allows for the charger to be slimmer, so as to nicely fit inside a jacket pocket, for example. This truly makes energy available whenever you need it.” Fuel cells use environmentally friendly technology to generate their own electricity, which can be used to charge one’s mobile phone, tablet, or camera completely independent of a power outlet or sunlight. For more information, please contact: Björn Westerholm, CEOE-mail: bjorn.westerholm@myfc.sePhone: +46 (0) 706 56 20 07 Press kit can be downloaded at:https://www.dropbox.com/sh/7cva3dhuqpi1xir/AADT3cMAKNaUSGNA80z4tICfa?dl=0

Financial Statement, January – December 2014

October to December 2014 (2013) · Net turnover totalled SEK 377.0 million (SEK 147.1 m), SEK 220.1 million (SEK 10.5 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 156.6 million (SEK 47.6 m), SEK 103.1 million (SEK 0) of which derived from sales of OLYSIO® and SEK 53.5 million (SEK 47.6 m) from sales of other pharmaceuticals. · The profit/loss after tax was SEK 147.3 million (SEK 19.3 m). · Basic and diluted earnings per share totalled SEK 4.71 (SEK 0.62) and SEK 4.67 (SEK 0.62), respectively. · The cash flow from operating activities amounted to SEK 505.4 million (SEK 75.6 m). January to December 2014 (2013) · Net turnover totalled SEK 1,767.0 million (SEK 446.1 m), SEK 1,399.0 million (SEK 10.5 m) of which comprised royalties for simeprevir. · Revenues from Medivir’s own pharmaceutical sales totalled SEK 366.8 million (SEK 176.1 m), SEK 186.4 million (SEK 0) of which derived from sales of OLYSIO® and SEK 180.4 million (SEK 176.1 m) from sales of other pharmaceuticals. · The profit/loss after tax was SEK 1,132.7 million (SEK 16.0 m). · Basic and diluted earnings per share totalled SEK 36.24 (SEK 0.51) and SEK 35.90 (SEK 0.51), respectively. · The cash flow from operating activities amounted to SEK 1,009.4 million (SEK 43.0 m). · Liquid assets and short-term investments at the period end totalled SEK 1,395.6 million (SEK 402.2 m). The royalties from the current quarter are not included in these items. Significant operational events During Q4 2014 · A Capital Markets Meeting focusing on the updated company strategy was held on 16 October. · Medivir presented data from the cathepsin S inhibitor programme for the treatment of neuropathic pain at the 15th World Congress on Pain. · The launch of the phase II study, IMPACT, for the evaluation of simeprevir in combination with sofosbuvir and daclatasvir in patients with decompensated cirrhosis of the liver was announced.     · Medivir entered into an agreement with Swedish county councils regarding risk sharing in connection with the treatment of hepatitis C with OLYSIO®. The agreement offers the county councils and Medivir an increased degree of predictability with regard to treatment costs and the use of OLYSIO®. · The U.S. Food and Drug Administration (FDA) approved OLYSIO® (simeprevir) in combination with sofosbuvir as an all-oral, interferon- and ribavirin-free treatment option. · Medivir convened an Extraordinary General Meeting on Thursday, 20 November 2014, at which a voluntary share redemption programme for a total of ca. SEK 625 million was approved. The programme will be conducted during the first quarter of 2015. · MIV-802 was selected as a candidate drug for Medivir’s nucleotide-based polymerase inhibitor project for the treatment of hepatitis C. After the end of Q4 · Global net sales of OLYSIO® (simeprevir) totalled USD 321 million, USD 256 million of which derived from sales in the USA during the fourth quarter of 2014. Medivir’s royalties amounted to SEK 220.1 million (EUR 23.1 m). · Medivir announced a reorganisation of the company’s management group effective 1 March 2015. · The terms and schedule for the voluntary share redemption programme were announced. · The phase II studies, COMMIT, for the evaluation of simeprevir in combination with daclatasvir and ACCORDION-I for the evaluation of simeprevir in combination with daclatasvir and sofosbuvir, began. · The Nomination Committee proposed a new Board of Directors, ahead of the 2015 Annual General Meeting. * All figures refer to the Group, unless otherwise stated. Comparisons in the Interim Report are, unless otherwise stated, with the corresponding period in 2013. Cross Pharma was divested from the Group on 30 June 2013. The CEO’s statement Our ongoing hepatitis C research has resulted in a new candidate drug2014 has been an historic year for Medivir. The most important event was, of course, the launch of OLYSIO®, a new pharmaceutical for the treatment of hepatitis C and which was developed in collaboration with our partner, Janssen. The launch has resulted in substantial income streams for Medivir, both from own pharmaceutical sales within the Nordic region, and in the form of royalty income through our partner, Janssen, from sales in other markets. Royalty income for these sales in the fourth quarter and the year as a whole totalled SEK 220.1 million and SEK 1,399.0 million, respectively. Medivir’s own Nordic market sales of OLYSIO® in the fourth quarter totalled SEK 103.1 million, while sales since the launch in the second quarter of 2014 now amount to SEK 186.4 million. The global hepatitis C market is an exciting one with an ongoing significant dynamic where only an extremely small propotion of diagnosed patients have received treatment to date. A number of new pharmaceuticals for the treatment of hepatitis C have been introduced, both internationally and on the Nordic market, in 2014, resulting in an increase in the competition faced by OLYSIO®. The Swedish Dental and Pharmaceutical Benefits Agency (TLV) has, however, stated that treatment with OLYSIO® is beneficial from a health economics viewpoint in the treatment of hepatitis C patients, and this past autumn saw a risk-sharing agreement reached between Medivir and the Swedish county councils offering both parties an increased degree of predictability with regard to treatment costs and the use of OLYSIO®. In November, Medivir’s partner, Janssen, presented real-world data for treatment with simeprevir and sofosbuvir, with and without ribavirin. These data were very positive and confirmed the positive results presented in the COSMOS study. The treatment results demonstrate a very high cure rate and a good safety profile, which is a very positive outcome now that competition is growing in the global market. Our research portfolio is developing according to plan. In December, MIV-802 was selected as a candidate drug from our internal nucleotide-based polymerase inhibitor project for the treatment of hepatitis C and has, in our opinion, every chance of proving a valuable addition to the pharmaceuticals currently available. The project has now entered the non-clinical development phase and we intend to present MIV-802’s antiviral and pharmacokinetic profiles in 2015. Our in-house development projects are currently conducting important preclinical safety studies. Cathepsin S is a protease that plays an important role in long-term neuropathic pain. In October, we presented data from the project involving our candidate drug, MIV-247, a cathepsin S inhibitor currently in non-clinical development for the oral treatment of neuropathic pain. The results to date are very promising and we look forward to the continued development of a new, effective and safe treatment alternative for the substantial group of patients who suffer from chronic neuropathic pain. MIV-711 is a cathepsin K inhibitor in clinical development for the treatment of osteoarthritis. The positive results we have seen from the initial clinical phase I studies confirm that MIV-711 has the potential to offer disease-modifying treatment of skeletal and cartilage-related diseases such as osteoarthritis. Nordic pharmaceutical sales have performed well during the quarter. Nordic Brands continued to report stable sales of SEK 53.4 million during the fourth quarter and of SEK 180.0 million during 2014 as a whole. Innovative Specialty Care and Nordic Brands collectively generated sales of SEK 156.6 million during the quarter and of SEK 366.8 million during 2014 as a whole, corresponding to a year on year increase of SEK 190.7 million.   An Extraordinary General Meeting held in November approved a voluntary share redemption programme for ca. SEK 625 million for which the final terms, approved by the Board of Directors on 30 January 2015, mean that every seventh share will be redeemable for a cash consideration of SEK 140 per share. We can now put a successful year to rest and look forward to 2015. Medivir will continue to be a research-based pharmaceutical company and will, in order to strengthen and develop our research portfolio, continue to build on our cutting-edge expertise in protease inhibitor design and nucleotide/nucleoside research, with the emphasis on infectious diseases and oncology. We will intensify our activities in the commercial development sphere and within our already strong commercial organisation with the aim of identifying new business opportunities for both our R&D operations and our Nordic pharmaceutical portfolio – activities that will lead to increased value generation and promote long-term profitability. Niklas PragerPresident & CEO   For further information, please contact:Niklas Prager, President & CEO, +46 (0) 8 407 64 30Ola Burmark, CFO, +46 (0) 725 480 580 Conference call for investors, analysts and the mediaThe 2014 Financial Statement will be presented by Medivir’s President & CEO, Niklas Prager, and members of the management group.Time: Friday, 27 February 2015, at 14.00 (CET). Phone numbers for participants from:Sweden +46 (0)8 566 426 94Europe +44 20 342 81431USA +1 855 753 2236 The conference call will also be streamed via a link on the website: www.medivir.se Financial calendar:The 2014 Annual Report will be published on 7 April 2015.The Annual General Meeting will be held on 5 May 2015.The Interim Report for January–March 2015 will be published on 5 May.

Lower production and restructuring marks fourth quarter financials

Stavanger, 27 February 2015: Operating revenues for Norwegian Energy Company ASA (“Noreco”) were reduced in the fourth quarter 2014 due to low oil production. Net loss after tax was NOK 1.7 billion, impacted by several significant items, including impairments and other financial items. Operating revenues in the fourth quarter 2014 were NOK 145 million, down from NOK 255 million in the same quarter 2013. Operating income was heavily influenced by low output from the Huntington field, which only produced 616 barrels of oil equivalents per day to Noreco during the quarter, and lower realised oil price. Total impairments amounted to NOK 570 million after tax, which include NOK 241 million in write-downs after tax on Huntington and NOK 292 million in write-downs after tax on the Cecilie and Nini fields. Partial write-offs of deferred tax assets in Denmark and the UK have also impacted the net results in the quarter by NOK 618 million. Financial expenses include NOK 510 million which is related to default of all bond debt now reclassified to current liabilities. “The fourth quarter was marked by a series of events and circumstances, which prompted us to accelerate our efforts to build a new financial platform for the company. In early February we presented a restructuring proposal, which we hope that bondholders and shareholders will approve in their respective meetings on 2 and 3 March”, says Tommy Sundt, CEO of Noreco. In the report for the fourth quarter, the Board of Directors of Noreco repeats that the restructuring proposal represents the best way forward given the circumstances, as the present alternative is bankruptcy. For further information, please see the attached report for the fourth quarter 2014 and a summary presentation of the key financials. Contact:Odd Arne Slettebø, CFO. Tel.: +47 992 83 900Or email: investorrelations@noreco.com

Finnair highlights cost savings success, outlines vision for profitable growth in 2014 Annual Report

Finnair Plc Stock Exchange Release 27 February 2015 12:00  EET Finnair has published its Annual Report for 2014, measuring and accounting for the financial, economic, social and environmental performance of the Finnair Group, as well as identifying and explaining the strategic business ramifications of that performance. The major highlights of 2014 include the successful cost-savings agreements reached with the company’s employee groups that enabled Finnair to complete its ambitious program, begun in 2011, to permanently reduce annual costs by 200 million euros. As part of an effort to sustainably grow revenue while also controlling costs, Finnair also introduced several new product upgrades and service updates and began implementing its new commercial strategy. The company also began extensive preparations for the delivery of 19 Airbus A350 XWB aircraft, the first four of which are due to enter service in the second half of 2015. On 11 February Finnair published its Financial Statements for 2014, as well as the Report of the Board of Directors, Auditor’s Report, Remuneration Statement and Corporate Governance Statement. The Annual Report, which includes these documents and contains no new material information, is prepared according to G3 disclosure guidelines established by the Global Reporting Initiative (GRI). Shareholders, investors, analysts, media, customers, employees, other interested stakeholders and the general public at large comprise the report’s intended audience. Finnair has reported on environmental sustainability since 1997, and in 2008 became one of the first airlines to report according to GRI guidelines. The GRI, formed with the support of the United Nations Environment Program, is the most widely recognised international authority on sustainability reporting.  “The Annual Report is our premier forum for open, transparent engagement with all stakeholders about Finnair’s performance and value creation,” says Finnair CEO Pekka Vauramo. “In addition to detailed information and analysis, the report also takes into account larger commercial, regulatory and social trends, and explores how Finnair can succeed in the marketplace today and tomorrow. The report is addressed to all with a stake in Finnair and who care for its future.” The report is available digitally (PDF format) at www.finnairgroup.com/en

WORLD CHALLENGE EXCELS IN 2015 INTERNATIONAL SAFETY AWARDS

Whilst many companies are measured in terms of their workplace health and safety, the leading provider of experiential student travel was measured against its operational safety around its expeditions and safeguarding of participants and staff. More than 500 organisations won an International Safety Award for 2015, and the winning organisations span all sectors and range from the United Kingdom, Africa, Asia, Europe, the Middle East and the West Indies. World Challenge Global Operations Director Stuart Morris was understandably delighted with the 60 out of 60 score only a year after picking up a merit in the same category. He said: “World Challenge is committed to running the safest expeditions possible. Each year we take over 10,000 young people on educational expeditions to over 45 destinations. “We have worked hard over the last 26 years to develop an excellent reputation for our approach to safety and how we operate. “Our policies and procedures reflect industry good-practice and comply with The British Standard for Overseas Expeditions and Fieldwork (BS 8848) and Learning Outside the Classroom (LOtC). “This award is a fantastic achievement and testament to the hard work across the board.” Neal Stone, acting Chief Executive of the British Safety Council, congratulated World Challenge on its success. “On behalf of the Trustees and staff of the British Safety Council we warmly congratulate World Challenge and its employees on gaining an International Safety Award with distinction for 2015. All of those working at the company have made this award possible and they should rightly be proud of their achievement,” he added. Further information about World Challenge can be found at: www.world-challenge.co.uk  

Financial Statements 1 January - 31 December 2014, Zinzino AB (publ)

SUMMARY OF Q4, 2014 (compared with the same period in the previous year, 2013) Total revenue amounted to SEK 114.6m (82.2m), which corresponds to sales growth of 39.5 per cent for the group, compared with the previous year. Pre-tax profit amounted to SEK 5.2m (5.0m), corresponding to earnings per share of SEK 0.18 (0.17). Results were weighed down by non-recurring costs of a total of SEK 3.1m (0.0m). FOURTH QUARTER, Q4, 2014, (compared with the same period in the previous year, 2013) · Total adjusted revenue amounted to SEK 114.6m (82.2m), corresponding to growth of 39.5%. · Operating profit before depreciation amounted to SEK 7.3m (5.3m) and the operating margin before depreciation was 6.4% (6,4%). · Profit before tax amounted to SEK 5.2m (5.0m). Earnings per share before tax amounted to SEK 0.18 (0.17). · Profit after tax totalled SEK 19,5m (4.5m), which the minority interest amounts to SEK 1.5m (0.5m). Net margin 17.0% (5.5%). · Deferred tax assets on tax loss carryforwards have a positive impact of SEK 14.5m. 1 JANUARY – 31 DECEMBER 2014 (compared with the same period in the previous year, 2013) · Total adjusted revenue amounted to SEK 357.7m (254.5m), corresponding to growth of 40.5%. · Operating profit before depreciation amounted to SEK 21.4m (11.2m) and the operating margin before depreciation was 6.0% (4,4%). · Pre-tax profit tax totalled SEK 18.4m (10.4m). Diluted earnings per share before tax amounted to SEK 0.63 (0.35) after dilution. · Profit after tax amounted to SEK 32.7m (9.8m), which corresponds to a net margin of 9.1% (3.9%). Minority interest amounts to SEK 2.8m (0.8m). · Deferred tax assets on tax loss carryforwards have a positive impact of SEK 14.5m. · Liquid assets at the year-end totalled SEK 42.8m (10.9m). · The Board proposes that for the fiscal year 2014 dividend of SEK 0.25 (0.10) per share. KEY EVENTS DURING THE PERIOD 1 JANUARY - 31 DECEMBER 2014 · Admission to trading on Nasdaq OMX First North took place on 11th December 2014. The purpose of the listing was to make trading in the company's shares easier for foreign shareholders and to attract new investors. Erik Penser acts as Certified Adviser. · Zinzino AB has acquired 85% of Faun Pharma AS – an investment totalling SEK 10m. · In December 2014, Zinzino AB acquired the outstanding 90% of Bioactive Foods AS, which thus became a wholly owned subsidiary of Zinzino AB. The company has in cooperation with Zinzino developed, researched and produced Zinzino's Balance products. · New product launch: Xtender, which is designed to protect, preserve and regenerate cells and tissues. · Launch of a new flavour for BalanceOil: Orange/lemon/mint. · Investments in a new IT system have resulted in new investments of SEK 2m of which SEK 0.5m in 2014 and impairment of intangible assets of SEK 1.1m, taken as a one-time expense in the fourth quarter of 2014. · The group gained 22,738 (17,165) new customers in the fourth quarter. The sales force was expanded by 2,468 (3,057) distributors. · Turnover distribution by product area (as % of turnover) was 29% for Zinzino Coffee and 71% for Zinzino Food in the fourth quarter.   COMMENT BY CEO DAG BERGHEIM PETTERSEN: “2014 was yet another strong year and we delivered on our promise to the market of growth and improved profitability. We achieved growth of around 40% not only in the last quarter but also in the remainder of 2014 - strong figures, which are better than we had expected at the beginning of the year. Profitability also improved, with an operating margin that now exceeds 5% of our total revenue of more than SEK 350m. We consider the main factors for the improvement in profitability compared with the previous year to be our focus on growth and increased customer quotas, that is, number of customers per salesperson. I am both delighted and proud of our financial development, but even more important are perhaps the decisions on, and implementation of, the investments which will make us better equipped and more efficient in the coming years. In the final quarter of 2014 we acquired our own production capacity through the investment in Faun Pharma. In addition, we acquired 100% of Bioactive Foods AS, a company we already had a stake in. These investments will give us an excellent platform for product development and will enable us to reduce our materials costs. This, in turn, will give us a competitive advantage and improved margins, safeguarding Zinzino's operations and future. The change in trading platform to Nasdaq OMX First North is yet another important step we have taken this year and a natural step in our strategic plan concerning international expansion of the company. Currently, we are active in 12 markets. Our goal is to be established in 20 markets by 2020. In 2015, our aim is to establish operations in Germany and Canada, both countries with a large population and large potential markets for Zinzino. The expansion into both markets will be implemented in a cost-efficient manner with the help of the existing organisations in Sweden and the USA. Customer growth and improved efficiency are deeply ingrained in our culture and strategy. On the strength of all the investments carried out in 2014, in 2015 we will continue to actively work towards continued growth in all markets, integration and improved efficiency of Bioactive Foods and Faun Pharma, entering new markets, strengthening our organisation, improved IT structure, improved margins on goods sold and improved profitability. Our primary focus in 2015 is growth and many new customers. We want to achieve growth of at least 25% and an improved result every year for the next three years.” Dag Bergheim Pettersen, CEO, Zinzino AB   For a full report, please see the attached PDF. This information comprises information that Zinzino AB must disclose under the Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on27th February 2015.  INFORMATION ABOUT THE COMPANY Zinzino was founded under the name Zinzino Holding in autumn 2007. In 2009, the company acquired 93% of the equity and 97% of the votes in Zinzino Nordic AB, partly by means of a non-cash issue and partly by means of a private placement. Zinzino Nordic is a sales company that uses independent distributors to market and sell products for commission via so-called direct sales. NEXT REPORTThe Q1 quarterly report will be published on 22th May, 2015. For further information:Dag Bergheim Pettersen, CEO, Zinzino, Tel. +47(0) 93 22 57 00Fredrik Nielsen, CFO, Zinzino, Tel. +46 (0) 707 900 174Photos for publication free of charge:Anders Ekhammar, Tel. +46 (0) 707 462 579www.zinzino.se

FOURTH QUARTER AND YEAR END REPORT 2014

FOURTH QUARTER · Total revenues of $9,025’ (545’) · EBITDA of $7,356’ (-399’) · Net result of $2,120’ (-3,643’) · Earnings per share $0.07 (-0.25) TWELVE MONTHS · Total revenues of $16,200’ (2,315’) · EBITDA of $10,054’ (-681’) · Net result of $4,476’ (-3,828’) · Earnings per share $0.19 (-0.30) SIGNIFICANT EVENTS DURING THE QUARTER · Finalized and integrated the acquisition of Gas Ventures LLC. · Development program for KYTX and acquisition of neighbouring field. · Divestment of non core asset Delano. · Drilled and polymer treated Zimmerman Butte, Wyoming. · Fracking of Pieda Negra. · Drilling program commenced at Orange with GLHF #37 as the first well. · Average daily gross production of 1,204 barrels of oil equivalent (81). · OPEX (excl. production taxes and workovers) per barrel of oil equivalent amounted to $18.2. · Hedge portfolio valued to $5,659’ as per 31 December, 2014. SUBSEQUENT EVENTS · Divested non core assets Gernt. · Successful drilling of GLHF #37 with an initial daily production of 240 boe. · Successful drilling GLHF #38 and with an initial daily production of 300 boe. · Re-fracked Pieda Negra with unsuccessful result.    · Signed a Heads of Agreement with US-listed Pedevco for the sale of the US Operations. US$ Thousand Q4 Q4 FY FY  2014 2013 2014 2013Total revenues 9,025 545 16,200 2,315Revenues from oil and gas sales 2,597 395 6,964 2,166Gross profit 743 87 3,180 1,120Gross margin, % 29% 22% 46% 52%EBITDA 7,356 -399 10,054 -681EBT 2,120 -3,642 4,476 -3,811Net result 2,120 -3,643 4,476 -3,828EPS (in US$) 0.07 -0.25 0.19 -0.30Production (boepd) 1,204 81 632 69 For further information please contact: Susanna Helgesen, CFOPhone: +46 708 27 86 36US phone: +1 281 558 8585E-mail: sh@domeenergy.com About Dome EnergyDome Energy AB. is an independent Oil & Gas Company publicly traded on the Nasdaq OMX First North exchange in Sweden (Ticker: DOME (http://www.nasdaq.com/symbol/els/dome)). Remium Nordic AB is the Company’s Certified Adviser. Headquartered in Houston, Texas, the Company’s focus is on the development and production of existing onshore Oil & Gas reserves in the United States. For more information visit www.domeenergy.com.